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ABSTRACT
THE APPLICATION OF ANALYTICAL ULTRACENTRIFUGATION WITH
FLUORESCENCE DETECTION SYSTEM TO THE STUDY OF
MACROMOLECULAR COMPLEXES IN BIOLOGICAL SYSTEMS
By
Wen Xi
University of New Hampshire, December, 2015

Using the novel technique of analytical ultracentrifugation with fluorescent detection
(AU-FDS), I have conducted the analysis of the properties of two types of intracellular
macromolecular complexes: the translational mRNP complex and the intermediate soluble
aggregates present in Huntington’s disease. With AU-FDS it is possible to differentiate a
broad size range of soluble molecules from complex mixtures and determine the size and
abundance of each individual complex based on its sedimentation rate under a centrifugal
field.

In the first part of my thesis, the characteristics of the translational repressor SBP1 was
determined by analyzing the mRNP complexes it was associated with. SBP1, an RNA
binding protein, plays a role in stress granules and P-body function which are involved in
mRNA degradation processes. SBP1, whose role in translation is unknown, was found to
co-immunoprecipitate the 77S monosomal translating mRNP complex. Two types of 77S
vi

complexes containing SBP1 were identified. The majority of the 77S complexes lacked other
translation initiation factors, suggesting that this 77S is in the late elongation/early
termination phase. SBP1 was also present in a 77S complex that contained other initiation
factors but may not be active in translation, possibly as it is located in P-bodies or stress
granules.

In the second part of this thesis, the ability of the huntingtin protein, HTT-103Q, to form
soluble aggregates was analyzed. HTT-103Q is a glutamine rich protein fragment previously
identified as a self-propagating protein capable of forming insoluble amyloids and to cause
Huntington’s disease. AU-FDS analysis identified soluble aggregates of HTT-103Q. A series
of intermediate aggregates with sizes in between 30S to 180S were observed that
dramatically changed in their abundance as a function of time. The deletion of chaperones
HSP70 or HSP104 strongly suppressed the presence of these complexes and correspondingly
suppressed amyloid formation and cell toxicity. In contrast, overexpression of the chaperones
had less effect on the formation of these soluble aggregates. I also studied the effects on
HTT-103Q aggregation of two aging factors known to be involved in amyloid aggregation.
Overexpression of HSF1 and deletion of SIR2 significantly impaired the production of the
HTT-103Q soluble aggregates. Overall, these results indicate that the 30-180S soluble
aggregates detected for HTT-103Q may be critical to amyloid formation and cell toxicity.

These combined studies indicate that AU-FDS can identify and characterize novel
macromolecular complexes in biological systems.
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General Introduction
Analytical ultracentrifugation (AU) is a classical method to determine the molecular weight
and size of protein and nucleic acids in biological researches. For decades, AU has been the
standard method to determine the characterization of macromolecules in solution. Without an
interaction with any matrix or surface, AU is able to monitor the sedimentation, under a
centrifugal field, of different components in solution. From this AU data the sizes and
quantities of these components can be calculated. AU can be used detect proteins and other
marcomolecules in solution using either a spectrophotometric system (AU-Abs) that detects
absorbances ranging from 190 nm to 800 nm or by a newly developed fluorescence detection
system (AU-FDS) that detects green fluorescent protein (GFP) (MacGregor I et al 2004).

As the centrifugation run begins, macromolecules start to deplete from the meniscus and form
a concentration boundary moving towards the bottom of the centrifugation cell (Fig 1). The
rate of the boundary movement of a spherical molecule can be defined as the sedimentation
coefficient s, which can be determined by the parameters given by the Svedburg equation:

𝑠=

𝑢
𝑀(1 − 𝜐𝜌) 𝑀𝐷(1 − 𝜐𝜌)
=
=
𝜔2𝑟
𝑁𝐴 𝑓
𝑅𝑇

Eq.1 Svedburg equation. Where u is the observed radial velocity of the macromolecule, 2r is
the centrifugal field, M is the molar mass,, the partial specific volume,  is the density of
the solvent, NA is Avogadro’s number and f is the frictional coefficient, D is the diffusion
coefficient, and R is the gas constant. The s-values are commonly reported in Svedberg (S)
units, which correspond to 10-13 sec (Lebowitz J et al, 2002).
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For all the samples we tested in the project, the S-values can be normalized as S20,w by the
given condition at 20ºC in water with the following equation:

𝑠20,𝑤

𝜂 𝑇,𝐵 (1 − 𝜐𝜌)20
= 𝑠𝑇,𝐵 (
)
𝜂20 (1 − 𝜐𝜌)

𝑇,𝐵

Eq. 2 Standard correction equation, where is viscosity, T, B are the experimental
temperature and buffer condition (Laue T et al, 1992).

The molecular weight of a spherical macromolecule can be calculated by the following
equation:

𝑀𝑊 = (𝑆20,𝑤 ∗ 3.16)

3/2

Eq. 3 Molecular Calculation

However, it is practically not possible to precisely calculate the MW with the S20,w, as
molecules tend not to be ideally spherical. A 2:1 length to width ratio subject has an S-value
1.4-fold smaller than an equal mass spherical subject due to a change in the frictional
coefficient.
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Fig. 1 Concentration boundary in centrifugal field
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AU has several advantages compared with other methods of characterizing biological
macromolecules. AU requires no chemical or physical contact to the samples. Samples are
required only to be soluble and the composition of the solution is immaterial, which allows
researchers to maximally retain the native state of the molecules by using an optimized buffer
system. Moreover, AU provides a broader detection range and a better resolution than other
methods as it monitors the sample movement in real time while sucrose gradient and
chromatography only takes a snapshot at a particular end point. Furthermore, AU is able to
distinguish different molecules/complexes in a mixture at one time, which requires no
secondary purification of the samples. AU samples can be prepared in a remarkable short
period of time, and even crude extract samples can be analyzed. Importantly, AU results can
easily be optimized for different purposes by simply changing the parameters in the
calculation program.

In this thesis, I used AU as the primarily method to conduct research on macromolecular
protein complexes. The complexes that were studied were the translational mRNP complex
and the intermediate amyloid propagation complexes in Huntington’s disease. The study of
the translational mRNP conventionally has relied on indirect methods such as in vitro
reconstitution of the mRNP, mass spectrometry, sucrose gradient and X-ray crystallographic
studies (Strunk BS et al 2009; Zhang C et al 2014; Sampath P et al 2011; Melamed D et al
2007). None of these methods is perfect. In vitro reconstitution methods are good for
studying the process of translation but only known factors can be tested. This makes the
reconstituted translation complex a minimized model that contains only necessary factors of
-4-

translation, and, therefore, in vitro reconstitution is not capable of recapitulating the actual
process of translation and all the non-essential regulatory factors of translation. The mass
spectrometric technique helps identify several potential translational factors in the complex,
but the analysis is based on fragmentized peptides not on the whole complex. The actual
stoichiometric composition of the complex is difficult to determine from mass spectrometric
procedures. Moreover, mass spectromety usually can only analyze a single molecule or
complex and cannot differentiate between different sized complexes in its analysis. The
sucrose gradient method is similar to AU as both use ultracentrifugation to differentiate
multiple complexes in solution. The difference is that sucrose gradient relies on the density
equilibrium whereas AU uses sedimentation velocity. This allows the size of complexes to be
quantified by S values from the AU results. In addition, the introduction of excessive amount
of sucrose in solution may affect the integrity of the complexes. AU also has the option of
FDS to detect GFP samples, a critical advantage since most yeast proteins have been tagged
with GFP in vivo. Moreover, sucrose gradient analysis can only be monitored at one moment
while AU analysis can be scanned over many time periods, providing better approximations
of protein complex presence. Most importantly, the identification of particular proteins in
sucrose gradient analysis is limited to taking only fifteen or so slices across the centrifugation
cell, creating imprecision in the actual location of proteins in particular complexes. In
contrast, AU analysis can take several hundred “slices” across the range of protein sizes,
increasing by several

orders of magnitude the precision for

locating protein

presence.Therefore, AU is a unique technique compared with these other methods. As
described, we can use AU to analyze the target translation mRNP in its native state, obtain
-5-

size and stoichiometric information, all without losing the native state of the complexes.

The analysis of Huntington’s disease amyloid propagation with AU is also a first attempt at
differentiating the actual aggregate sizes present in huntingtin aggregation. Previously, there
has only been one attempt made with AU to analyze this process (Olshina MA et al 2010).
However, only recombinant proteins and in vitro aggregation were analyzed, the speed of
centrifugation they used was only good for monomeric protein detection, and the effects of
chaperone abundance changes were not tested. Almost all the other previous research on the
amyloid formation have been focused on the detectable phenotypes of the cells. These studies
relied on canonical techniques like fluorescent microscopy and western blot analysis
(Krobitsch S et al 2000; True HL et al 2000; Meriin AB et al 2002). The presence of protein
aggregates was inferred from crude filter assays and SDS-PAGE analysis in which
aggregated proteins migrated at best as smears (Kimura Y et al 2001). The use of AU on
huntingtin aggregates makes it possible to observe ranges of aggregate sizes, how the
aggregates change in size during amyloid formation, and the effect of a various factors on
aggregate formation. These AU research analyses on aggregate formation may hence provide
a potential method for future studies in this area.

-6-

Chapter I Study of translational mRNP complexes associated with SBP1
in Saccharomyces cerevisiae

Introduction
Protein translation is a complex and highly organized process requiring the cooperation of
ribosomes and various protein factors. During the stages of translation, initiation, elongation,
and termination, different protein factors associate and dissociate from the translating
ribosome. These protein factors mediate the interactions between the ribosome and mRNA,
and, in addition, serve as the regulatory targets of translational regulation. To thoroughly
understand translational regulation, it is necessary to investigate what are the protein factors
associating with ribosomes during different translational stages. In the first part of this thesis,
I studied the role and presence of the SBP1 protein in translating ribosomal complexes. SBP1
is a single strand RNA-binding protein, which previously was found to be involved in mRNA
degradation and translational repression (Segal SP et al 2006).

-7-

Eukaryotic Translation Initiation
In eukaryotes, translation initiation relies principally on the cap-dependent pathway, which
requires the m7G cap on the 5’ end of the mRNA. The detailed mechanism of this pathway is
described in the following sections.

Assembling the Pre-Initiation Complex (PIC)
In the first step of initiation, a 43S pre-initiation complex (PIC) is assembled. To create the
43S complex, the tRNA carrying the methionine (Met-tRNAi) binds to the eukaryotic
initiation factor 2 (eIF2). eIF2, in turn, is activated by binding to one molecule of GTP, and
consequently forms the ternary complex (eIF2-GTP-Met-tRNAi). This ternary complex, with
other factors, eIFs 1, 1A, 3 and 5, then binds to a 40S ribosomal subunit, to form the 43S
pre-initiation complex (PIC).

Closed-loop mRNP
The mRNA is activated by another set of protein factors, with eIF4E binding to the 5'-Cap of
the mRNA and the poly(A) binding protein (PAB1) binding to the 3' Poly (A) tail of the
mRNA. eIF4G binds to both eIF4E and PAB1, forming a closed-loop complex (Mangus DA,
et al, 2003; Amrani N, et al, 2008), in which the head and tail of the mRNA is connected by
eIF4G. eIF4G also contains RNA binding sites, and facilitates as a scaffold the binding to
eIF4A and eIF4B. eIF4A is a DEAD-box helicase. Together with eIF4B, eIF4A promotes
conformational changes of the mRNA, thereby unwinding and activating the mRNA which
promotes the binding of the PIC.
-8-

Ribosome Assembly
The 43S PIC loads onto the closed-loop mRNA complex at the 5’ proximal regions of the
mRNA, thereby forming the 48S initiation complex. The 48S complex then moves linearly
along the mRNA, base-by-base scanning for the first AUG codon. This process is promoted
by eIF4A which removes the secondary structures on the 5’ untranslated region (5’UTR).
Once the start codon has been recognized, eIF2-GDP and eIF5 dissociate from the complex
and are replaced by the 60S subunit, which forms the translationally active mRNP. This
monosomal translating complex has been identified as a 77S translation complex (Wang et al
2012). Additional ribosomes coming on the 5’ end of the mRNA create polysomal translating
complexes that are much larger (116S and larger). Translation then processes through the
elongation phase.

-9-

Fig.1.1 Eukaryotic Translation Initiation
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Poly (A) binding protein PAB1
PAB1 (PABP in human) is an evolutionarily conserved protein that has a high binding affinity
to poly(A) sequences. During translational initiation, PAB1 is physically associated with the
poly(A) tail of the mRNA. PAB1 binds 25-30 nucleotides (Sachs AB et al, 1987), and
therefore for a typical yeast poly(A) tail of 75 A’s, one would expect three PAB1 molecules to
be bound. PAB1 consists of 577 amino acids and contains four highly conserved RNA
recognition motif (RRMs) domains. Binding to poly(A) stimulates PAB1 to bind eIF4G and
form the closed-loop mRNP. As described above, these interactions are important for aiding
the formation of the activated 43S complex, the forming of the 48S complex and the further
assembly with the 60S complex to form the 77S translating complex (Wang X. et al 2012).
Deletion of the PAB1 gene results in lethality to yeast (Wyers F et al 2000). Moreover, PAB1
is known to control the length of the poly(A) tail of mRNA during different stages of
translation (Minvielle-Sebastia et al., 1997; Brown et al., 1998). There are also interactions
between PAB1 and the mRNA deandenylase PAN2/PAN3, allowing the trimming of the
poly(A) tail of newly transcribed mRNA from more than 200 nucleotides into its final length
of about 50 to 90 nucleotides. Binding of PAB1 also stabilizes the mRNA by preventing
decay. mRNA degradation generally starts with the releasing of PAB1 followed by the
shortening of the poly(A) tail (deadenylation). (Zhang C. et al 2013)
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Eukaryotic Translation Termination
Translation termination takes place when one of the stop codons enters the ribosomal A site.
Eukaryotic termination factor 1 (eRF1), a protein factor structurally similar to a tRNA, is
responsible for recognizing and interacting with the stop codons. (Fig. 1.2) Driven by the
hydrolysis of GTP by eRF3 (bound to eRF1), the newly synthesized peptide chain is released.
The ribosome is dissembled by eRF3 and may be recycled back to the same mRNA for
another round of translation, if the mRNA does not enter degradation (Pisarev et al., 2007).
However, the ribosomal recycling factors (RRFs) mediating the recycling process are only
found in prokaryotes: to date no homologs of RRF have been discovered in eukaryotes.
Instead, eukaryotic ribosomal recycling is promoted by the ABC family protein ABCE1
(RLI1 in yeast) (Hirokawa et al., 2005; Hirokawa et al., 2006). The detailed mechanism of
eukaryotic translation termination is still not fully understood yet.

Fig. 1.2 Translation termination
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mRNA Turnover
mRNA Degradation
The degradation of mRNA plays an important role in translational regulation as well. In
eukaryotic cells, mRNA degradation is usually initiated by shortening of the 3’ poly(A) tail, a
process known as deadenylation, followed by the removal of the 5’ cap structure (decapping)
by DCP1/DCP2 and 5’-3’ exonucleolytic digestion of the mRNA by XNR1. An alternative
3’-5’ degradation by exosome may also occur, at a slower rate.

P-body mRNA degradation
Previous studies show that translation and mRNA degradation are usually two competitive
pathways in cells. As described, the removal of the cap structure, which is a key factor in
translational initiation (known as “cap” dependent translational initiation), is also a key step
in mRNA degradation. Moreover, initiation factors binding to the mRNA block the decapping
of mRNA by DCP1/DCP2 (Dunckley, T. 1999), and translation inhibitors stimulate mRNA
degradation (For review, see Balagopal, V. et al. 2009). Studies in yeast suggest that the
degradation of mRNA starts with the transition of translation mRNP into degradation mRNP,
with the translation machinery being replaced by the degradation machinery. The degradation
mRNPs are then concentrated in mRNP granules called processing bodies (P-bodies) (Fig.
1.3). Although their complete composition is not yet known, P-bodies are found to including
the decapping enzymes DCP1/DCP2, the activators of decapping DHH1/RCK/p54, PAT1,
SCD6/RAP55, EDC3, the LSM1–7 complex, and the exonuclease, XRN1 (Parker, R. 2007).
In general, P-bodies are considered to be essential to the degradation of mRNA and also to
- 13 -

play roles in nonsense-mediated mRNA decay, adenylate-uridylate-rich element mediated
mRNA decay, and microRNA induced mRNA silencing (Kulkarni M, et al 2010). However,
mRNAs entering P bodies do not all end up being degraded. Evidence shows there is some
mRNA concentrated in P-bodies that can reenter translation when translation is restored
(Brengues M et al 2005). So far, it is not clear what mechanism is determining the fate of
mRNA in P-bodies. As an important part of translational regulation, further studies on
P-bodies are necessary to be done.

Stress Granules
Another cytoplasmic granule (stress granule) formed under stress is observed that often docks
with the P-body (Nover, L. et al 1989). Similar to the P-body, the stress granule is also a
dynamic cluster of non-translating mRNP. Instead of associating with degradation factors as
in the P-body, mRNA in stress granules stimulated by heat shock (for instance) is associated
with the 40S ribosomal subunit and a subset of initiation factors eIF4E, eIF4G, PAB1
(Anderson P. et al 2008). Although, the exact composition of stress granules is not fully
understood yet, several findings suggesting stress granules have variable compositions under
different types of stress. Stress granules formed under glucose deprivation do not contain the
40S subunit, as an example. This difference in composition is a result of different blocks in
translational initiation caused by the different stresses (Wang et al., 2012).

According to their composition and behavior, stress granules are likely to temporarily hold
the mRNPs. mRNA in stress granules may either turn back to translation after removal of the
- 14 -

stress, or enter P-bodies, with translational initiation factors being replaced with degradation
factors, in which it proceeds to decay. A reverse transition is also observed during glucose
deprivation in which stress granules are formed after the formation of P-bodies, suggesting
the flow of mRNA in the direction of translation → P-body → stress granule (Buchan JR.
2008).

Fig. 1.3 The Life-Cycle of mRNA
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SBP1
Previously known as SSB1, SBP1 is a single-stranded RNA binding protein that contains two
RNA recognition motifs (RRM) domains (Fig. 1.4). Initially, SBP1 was localized to the
nucleolus and was found to associate with small nucleolar RNA snoRNA10 and snoRNA11
(Clark MW et al 1990). These data suggested that SBP1 was involved in ribosome biogenesis.
However, deletion of SBP1 did not lead to any notable phenotype in yeast. Later studies have
shown that in addition to the ability to bind with RNA, SBP1 could interact directly with
eIF4G to suppress translation (Rajyaguru P et al 2012). SBP1 could also suppress a
conditional allele in a decapping enzyme. Overexpression of SBP1 significantly reduced the
overall half-life of mRNA by promoting both 5’-3’ and 3’-5’ mRNA degradation, thereby
rescuing strains with a lethal degradation defect. These data suggested a role for SBP1 in both
translational repression and mRNA degradation.

In support of these roles, SBP1 was also found to regulate the formation of P-bodies under
the stress of glucose deprivation. For example, SBP1 was co-localized with P-bodies and
stress granules, and deletion of Sbp1 could affect the aggregation of P-bodies (Segal SP et al
2006, Mitchell SF et al 2013). Furthermore, our lab has previously identified SBP1 as a
component of the mRNP active in translation, supporting a role for SBP1 in the process of
translation (Zhang C et al 2014).

- 16 -

Fig. 1.4, Blastp of SBP1

For the first chapter of this thesis, the primary subject was to identify the role of SBP1 in
translation. This problem was addressed in particular by determining the composition and
function of the mRNP complexes that co-immunoprecipitate with SBP1. We had successful
experience on performing affinity purification on protein complexes associating with FLAG
peptide tagged translational protein factors in previous studies in our lab. As described above,
AU analysis would allow us to distinguish protein complexes by size from a mixture of
complexes. In this project, a Flag peptide tagged SBP1 expressing plasmid was constructed
and several strains of yeast expressing FLAG-SBP1 were created. In contrast with our
previous findings using FLAG-PAB1 to identify translation complexes (Wang et al 2012 and
Zhang et al 2014), the complexes associating with SBP1 were found to have low abundance
of other protein factors considered to be critical to translation initiation. These data suggested
that such FLAG-SBP1 complexes are more likely close to the end of the mRNA life after the
initiation factors have been removed from the mRNA. Stoichiometric analysis using AU-FDS
conducted with these strains suggests that SBP1 is associating with a different set of
translating mRNPs than is PAB1.

- 17 -

Materials and Methods
Cloning of FLAG-SBP1
Vector pWX01 used for expressing FLAG-SBP1 was a derivative of vector pG-1 (Fig. 1.5),
which is a high copy expressing vector containing a yeast glyceraldehyde-3-phosphate
dehydrogenase gene (GPD) promoter and the TRP1 gene for yeast transformant selection
(Schena M et al 1991). A FLAG-peptide gene sequence and four extra cloning sites were
inserted in the pG-1 vector between BamHI and SalI, to create a vector that fuses a FLAG-tag
to the N’ terminal of the proteins expressed with this plasmid.

pWX01 insert sequence:
5’-…GGATCC ATG GACTACAAGGATGACGACGACAAG GGTACC CCATGG
BamHI

FLAG

KpnI

NcoI

GAGCTC CTCGAG GTCGAC…-3’
SacI

XhoI

SalI

Fig. 1.5 pG-1 expression vector
The fragment of the SBP1 gene was amplified from a previous SBP1-GFP construct by PCR,
- 18 -

with following primers:
Sbp1-Upstream 5'-GGCA GGTACC ATGTCTGCTGAAATTGAAGAA-3’
KpnI

Sbp1-downstream 5'-CCG CTCGAG TTCTTGCTTTTCTTCAGAACC-3’
XhoI

In this case, digestion with restriction enzyme KpnI allowed insertion of the 5’end of SBP1
and with XhoI at the 3’end.

The plasmid pWX03 was constructed with the insertion of the SBP1 gene between designated
sites of the vector pWX01. The expression of FLAG-SBP1 was verified by western blot
analysis with Anti-FLAG antibody. A trp1-1/URA3 (pWX03tU) conversion was made by
using ‘marker swap’ plasmids (Cross FR, 1996) through homologous recombination.

Yeast growth conditions and treatments
Yeast strains used in this study are listed in Table 1. All the yeast strains are isogenic (except
for RP2191), with the DNA sequence encoding GFP fused to a different gene for each
individual strain as described. Yeast cells were grown at 30ºC in synthetic complete (SC)
medium until mid-log phase (OD600 = 0.8-1.2), with 2% glucose and appropriate amino
acids deficiency for strain selection, respectively (Kaiser C et al 1994). For glucose
deprivation samples, yeast pelleted cells were washed twice with glucose-free medium and
incubated for an extra 10 minutes without glucose. For samples involving reinitiation of
translation after glucose depletion, 2% glucose was added back to the culture after the
incubation of 10 minutes in glucose-free medium, with an extra incubation of 1 or 10 minutes
depending on the experiment. In AU analysis, 200 mL yeast cultures of each samples were
- 19 -

used, yeast pellets were collected by 8000 g centrifugation for 3 minutes and generally were
stored at 80ºC for later use. The protein content of yeast cells was extracted by the glass bead
method with cell lysis buffer containing 1mg/mL of PMSF, 1:500 dilution of Protease
Inihibitor Cocktail (Sigma-Aldrich P8215), 0.05 M of Tris Base, 0.15 M of KCl, 2 mM of
MgCl2 and 10% glycerol.

The FLAG-tag and associated mRNPs were purified by affinity purification with 100 L of
ANTI-FLAG® M2 Affinity Gel (Sigma-Aldrich) at 4ºC for 2 hours, followed by a wash with
cell lysis buffer without the Protease Inhibitor Cocktail. The mRNPs were eluted with 500 L
of 0.2mg/mL FLAG® Peptide (Sigma-Aldrich) at 4ºC for 40 minutes.

Name

Genotype

RP1950/WX03tU
RPL6B/WX03tU

Mata ura3 leu2 his3 met15 eIF5B-GFP-[HIS3]
[URA3-Flag-SBP1]
Isogenic to RP1950 except RPL6B-GFP-[HIS3]

RPL7A/WX03tU

Isogenic to RP1950 except RPL7A-GFP-[HIS3]

RPL25A/WX03tU

Isogenic to RP1950 except RPL25A-GFP-[HIS3]

RP1946/WX03tU

Isogenic to RP1950 except CDC33-GFP-[HIS3]

RP1947/WX03tU

Isogenic to RP1950 except TIF4631-GFP-[HIS3]

RP2191/WX03tU

Mata leu2-3,112 trp1 ura3 his4 cup1::LEU2/PGK1 pG/MFA2
pG/PAB1-GFP(NEO) [URA3-Flag-SBP1]

RP2137/WX03tU

Isogenic to RP1950 except SBP1-GFP-[HIS3]

GSSD1/WX03tU

Isogenic to RP1950 except SSD1-GFP-[HIS3]

Table 1.1, Yeast strains used in this study.
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AU analysis
Samples were loaded to the two-channel charcoal/Epon60K sedimentation velocity cells,
with approximately 350 L per channel. The centrifugation was started with a speed of 15000
RPM, which was previously shown to be suitable for differentiating complexes ranged from
20S to 250S in size (Wang X. et al 2012).

All the experiments were conducted at a

temperature of 20ºC. For the AU-FDS analysis, at least 200 scans of samples were taken from
each experiment, in about 5 hours, a period of time enough for the major concentration
boundary to migrate to the bottom of the cell. For AU-Abs analysis, because only one sample
can be scanned in each scan, the scan numbers of each individual samples are determined by
the numbers of samples loaded to the device. A total of 300 scans were typically used for the
analysis. The raw data was analyzed by Sedfit (Schuck P. 2000), with the model c(s)
distribution and proper parameters (Fig. 1.6). The calculated data set of S-values was adjusted
by multiplying the viscosity factor of 1.52 for the presence of 10% glycerol in the buffer.
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Fig. 1.6 Sedfit parameters

Stoichiometry Analysis
The stoichiometry of the mRNP components in the 77S translation complex and other
complexes was calculated based on the fact that mRNP component quantities are proportional
to the size of the relevant peaks in the AU results. The size of a peak was calculated by
adding up all the c(s) values within the peak. The amount of a certain protein in the mRNP,
A(FDS), can be calculated from the AU-FDS result of the GFP tagged strains, and the amount
of total mRNP, A(Abs) can be calculated from the AU-Abs results of the samples, respectively.
Therefore, the abundance of the protein in the complex can be regarded as the peak size ratio
of A(FDS) to A(Abs) (Fig. 1.7). For a component known to be solely present in a complex, such
as ribosomal proteins in the 77S monosomal translation complex, the A(FDS)/ A(Abs) ratio can
be used as a standard of 100% to normalize with other components with unknown
stoichiometry in a particular complex.
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Fig. 1.7 The abundance calculated from the area of peaks
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Results
SBP1 is associating with the active translation mRNP
Because our previous studies had shown that SBP1 was a component of the 77S translating
ribosomal complex using FLAG-PAB1 to identify mRNA complexes, we were interested in
determining the type of complexes SBP1 was a part of. To investigate SBP1-containing
complexes, a FLAG-SBP1 fusion was created. By purifying the subsequent FLAG-SBP1
complexes, we would be able to identify the macromolecular complexes containing SBP1,
determine their characteristics, and potentially identify their components. I initiated these
studies by expressing FLAG-SBP1 in yeast, obtaining crude extracts from the yeast, and
affinity purifying FLAG-SBP1 complexes with Anti-FLAG agarose. The purified sample was
analyzed by AU-A260 to detect SBP1 complexes containing RNA.

Overall, a good absorbance signal was detected by AU-260 analysis (AU raw data, not
shown), indicating that the Anti-FLAG purification was successful and there was a decent
amount of RNA associating with SBP1. The calculated results (Fig. 1.8A) show a major peak
below 80S, suggesting the presence of a large abundance of ribosome in the complexes, as
well as two peaks at 60S and 40S that had more minor signals. Noticeably another major
peak was observed with an S-value below five. Because centrifugation speeds of 15000 rpm
were used in these experiments, complexes sized 20S-150S would be most readily
differentiated. Peaks below this range are generated by the Sedfit program with insufficient
sedimentation differentiation and were generally not studied further. A trace amount of
complexes with 110S were also barely visible.
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The major peak migrating just below 80S had a calculated S value of 74.6±2.74 based on five
experiments (Table 1.2). This size corresponds to the 77S monosomal translating complex
that has been previously identified. The identity of this putative 77S peak was confirmed by
two types of experiments. First, I combined FLAG-SBP1 with GFP-tagged ribosomal
components, RPS4B (small subunit, Fig. 1.8C) and RPL6B (large subunit, Fig. 1.8D) and
conducted AU-FDS analysis on the FLAG-purified material. In both cases, the major peak
observed migrated at 77S (summarized in Table 1.2), suggesting that both 40S and 60S
ribosomes were part of the 77S peak identified with FLAG-SBP1.

S values

Mean 77S complex size ±
S.E.M.

A260

77.8 80.1 74.7 73.2 76.3

76.4±2.68

RPS4B-GFP

75.5 73.2 70.9 73.2 75.5

73.7±1.92

RPL6B-GFP

77.8 73.2 75.5 70.9 70.9

73.7±3.00
74.6±2.74

Table 1.2. S values of the 77S peak in different tests
Legend: S values were determined following AU-A260 or AU-FDS analysis. The mean is
given ± the Standard Error of the Mean (S.E.M.).
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However, according to previous data (Wang X. et al 2012), both the free ribosome (80S) and
the monosomal translating 77S mRNP complex could be sedimenting in the 77S region. To
differentiate these possibilities I conducted a second analysis. The type of complex in this
region can be determined by ascertaining the effect of glucose depletion on the abundance of
the 77S peak. As shown previously, cellular translation stalls when glucose is removed from
the medium, the translating mRNP dissembles, and the free ribosomes are released in less
than 10 minutes. This results in an increase in the free 80S ribosome and a decrease in the
translating 77S mRNP (Wang X. et al 2012).

Using AU-260 analysis, the yeast sample treated with glucose deprivation (Glu+-) underwent
a dramatic decrease in the major peak around 80S (Fig. 1.8B), suggesting that SBP1 is a
component of the 77S monosomal translating mRNP complex that was previously identified
(Wang et al 2012). In contrast, there is no significant difference between the untreated and
treated results in the abundance of the minor 40S and 60S peaks, suggesting SBP1 is also
associating with a small portion of small and large ribosomal subunits which are
translationally inactive. This result could be linked with SBP1’s putative role in ribosome
biogenesis, which is previously reported associating with snoRNA10 and snoRNA11 (Clark
MW et al 1990).

Similarly, the abundance of the putative 77S complex observed following AU-FDS analysis
of RPS4B-GFP and RPL6B-GFP was found to be reduced following glucose deprivation (see
Fig. 1.8C and 1.8D, respectively). These results establish that the 77S peak identified in
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FLAG-SBP1 purified extracts is a translating monosomal complex and functionally related to
the 77S complex previously identified (Wang et al 2012). Importantly, FLAG-SBP1
co-purified with little material greater than 110S, unlike FLAG-PAB1 purifications. The latter
observation suggests that SBP1 does not primarily associate with polysomal material that
migrates at 110S and larger S values (Wang et al 2012).
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Fig.1.8 (A, B) AU-A260 of Flag-Sbp1 expression strain. AU-A230 and AU-FDS analysis
was conducted on FLAG-SBP1 purified material and analyzed by AUC as described in the
Materials and Methods. glu + refers to cells grown under steady-state elongation conditions
in the presence of glucose; glu + - refers to cells grown under glucose growth conditions
followed by depletion of glucose from the medium for 10 min.
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Fig.1.8 (C, D) AU-FDS of FLAG-SBP1 expression strain
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The 77S mRNP associating with FLAG-SBP1 is distinctive from the previous 77S mRNP
associating with FLAG-PAB1
The 77S monosomal translating complex identified with FLAG-PAB1 contained not only the
80S ribosomal components but a number of other factors: translation initiation factors PAB1,
eIF4E, eIF4G1, eIF4G2, translation termination factors eRF1 and eRF3, and the proteins
SSD1, SLF1, and PUB1 (Wang et al 2012; Zhang et al 2014). The presence of each of these
factors in the 77S complex identified with FLAG-SBP1 was subsequently determined.
Surprisingly, several essential translation initiation factors were only found in very low
abundance in this 77S complex, suggesting SBP1 may be primarily present in a 77S mRNP
that is different than that found with FLAG-PAB1. As shown in Fig.1.9 A, although the 77S
complex was present, the signal levels (peak heights) were significantly lower than the
abundance of ribosomal components when PAB1-GFP, eIF4E-GFP, eIF4G1-GFP and
eIF4G2-GFP were examined (Fig 1.9). Importantly, because the abundance of this 77S peak
observed for eIF4E, eIF4G1, and eIF4G2 was not significantly different as compared to the
no Flag control, the 77S peaks observed in these cases appear to result from non-specific
immunoprecipitation. Moreover, in the FLAG-SBP1 pull-downs, the abundance of the peaks
in the 77S region for each of the closed-loop factors was not affected by the glucose
deprivation treatment. These results suggest that whatever 77S monosomal translating
complexes that were being identified with FLAG-SBP1 that contained PAB1 and possibly
eIF4E and eIF4G were not translationally active. In contrast, as shown previously with
FLAG-PAB1, the abundance of all of these factors existing in the 77S monosomal translating
complex was correspondently reduced by glucose deprivation treatment for ten minutes
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(Wang et al 2012). Therefore, the 77S monosomal translating complex identified with
FLAG-SBP1 contains the 80S ribosomal proteins but low abundances of these other factors.

Fig.1.9 (A, B) Effect of glucose deprivation on PAB1-GFP/FLAG-SBP1 (A) and
eIF4E-GFP/FLAG-SBP1 (B). Analysis was conducted as described in Figure 1.8.
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Fig. 1.9 (C, D) Effects of glucose deprivation on translation factors eIF4G1 (C) eIF4G2 (D)
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Analysis of eRF1 presence in the FLAG-SBP1 complexes
In addition to the translation initiation factors PAB1, eIF4E, and eIF4G, the termination
factor eRF1-GFP was studied for its presence in FLAG-SBP1 complexes. As shown in
Figure 1.10A, eRF1-GFP exhibited a different pattern than the initiation factors with
FLAG-SBP1. eRF1 is known as a termination factor that recognizes the STOP codon and
initiates the release of translation machinery from the mRNA. eRF1 was previously identified
as a component of the 77S complex (Zhang C et al. 2014) and in vitro studies indicate that it
is present during translation initiation (AMRANI N et al. 2008). When purified by
FLAG-SBP1, a set of eRF1-GFP peaks were observed. A 70S peak was observed, possibly
the 77S complex, and there were also two large peaks running at 15S and 25S, which are
possibly merged from multiple smaller smear peaks based on the shape of the peaks.
However, in contrast to the decrease of total 77S monosmal translating complex with
FLAG-SBP1 following the glucose deprivation treatment (Figure 1.8), the overall signal of
eRF1-GFP including the putative 77S peak increased. The increase 77S peak indicates that
eRF1 is not part of the 77S monosomal translating complex, but it may be present with SBP1
in some other type of monosomal complex.

Translation repressor DHH1 does not co-purify with SBP1
Because SBP1 is a translational repressor, it was possible that other translational repressors
might be associating with it. DHH1 is one such repressor that has been shown to function
relatedly to SBP1. DHH1 is described as a P-body component involved in translation
repression and RNA degradation (Chang LC et al 2012; Carroll JS et al 2011). Like SBP1,
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deletion of DHH1 also affects the rate of mRNA degradation, while double deletion of DHH1
and SBP1 completely disrupts the ability of mRNA degradation and results in lethality to
yeast cells (Segal, SP et al 2006). DHH1 and SBP1 are considered to be involved in two
pathways of mRNA degradation which are independent to each other. However, as analyzed
by AU-FDS, DHH1-GFP gave no detectable signal in the FLAG-SBP1 purifications (Fig.
1.10B). Our experimental results showing that DHH1 does not associate with SBP1 supports
the current understanding of that these two factors may be functioning in distinct pathways.
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Fig. 1.10 AU-FDS analysis of translation terminator eRF1 and repressor DHH1
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mRNA binding proteins SLF1, SSD1 and PUB1 are not present in the SBP1 complexes
In addition to SBP1, three other mRNA binding proteins, SLF1, SSD1 and PUB1 were found
previously to be present in FLAG-PAB1 purified 77S translating complexes (Zhang et al
2014; Richardson et al 2013). SLF1 is a regulator of mitochondria and is involved in the
oxidative stress response. SLF1 is further related to the response of oxidative stress by
activating a set of antioxidant and other proteins required for oxidant tolerance
(Chatenay-Lapointe M et al 2011; Kershaw CJ et al 2015). SSD1 controls cell wall
remodeling by repressing translation of proteins involved in wall expansion (Uesono Y et al
1997; Jansen JM et al 2009; Wanless AG et al 2014). PUB1 is a highly abundant poly-U
binding protein co-localizing in stress granules which binds to the 77S mRNP during
translation as well as stress conditions. Binding of PUB1 to the AREs of 3’UTR protects
mRNA from decaying. (Duttagupta R et al 2005). I subsequently tested whether any of these
three factors were present in the FLAG-SBP1 77S complex (Fig. 1.11 A, B and C). None of
these mRNA binding proteins were identified as components of the protein complexes
purified by FLAG-SBP1. Unlike translation initiation factors eIF4E, eIF4G and PAB1, these
three factors were completely excluded from the 77S mRNP associating with SBP1. It is
currently not clear the role of these three factors in the 77S mRNP, but their absence in
FLAG-SBP1 purified complexes supports the finding that the FLAG-SBP1 77S mRNP is in a
different state of translation than is the FLAG-PAB1 77S complex.
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Fig. 1.11 AU-FDS analysis of GFP-tagged strains SLF-GFP (A), SSD1-GFP (B), PUB1-GFP
(C)
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Stoichiometry analysis of the SBP1 associated 77S complex
To more specifically analyze the difference of the 77S complex that co-purify with the
FLAG-PAB1 and FLAG-SBP1 proteins, the stoichiometry of the different GFP-tagged
proteins in the respective 77S complexes was calculated. As described in the Materials and
Methods section, the absolute abundance of a target protein can calculated based on the area
of the 77S peak observed in the AU-FDS analysis of the GFP-tagged protein as normalized
by to the total protein content of the 77S complex in the same sample as analyzed by AU-260.
The stoichiometry of each of the GFP tagged proteins was then calculated setting
RPS4B-GFP as 100% (Table 3). Importantly, most ribosomal components have more than
one genomic copy within the genome. We chose the RPS4B molecule as our standard for one
protein per 77S ribosome, as it has previously been shown that the RPS4A paralog of RPS4B
is not efficiently expressed in yeast (573 PRS4A molecules versus 102000 RPS4B molecules
per cell) (Ghaemmaghami S, et al. 2003). Another internal reference, RPL7A, was also used
as it was also dominantly expressed as compared to RPL7B (101000 RPL7A versus 7800
RPL7B molecules per cell). Finally, as shown in Table 3, the large subunit component
RPL6B has only half of the abundance in the 77S complex of that of RPS4B. This is because
a paralog RPL6A without GFP-tag is expressed at a similar level in the cell (37100 RPL6A
versus 38400 RPL6B molecules per cell). Despite possible experimental errors and slight
variations among these three ribosomal GFP-tagged proteins, the calculated stoichiometry of
ribosomal components to each other is close to our expectation.

In Table 1.3, the stoichiometry data from previous FLAG-PAB1 analysis (Wang X, 2013) is
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also listed. In FLAG-PAB1 pull-downs, 56% of the 77S complex contains eIF4E and 34% of
them contains eIF4G (20% of eIF4G1 and 14% of eIF4G2), which is consistent with a
translating mRNP. In contrast, the 77S complex in FLAG-SBP1 pull-downs contains only 3%
eIF4E and 1.2% eIF4G. These values for eIF4E and eIF4G are probably overestimates given
that no significant detection of these proteins were observed above the background control.
These results indicate that the majority of this FLAG-SBP1 77S complex is not at the same
stage of translation as is the FLAG-PAB1 77S complex. In addition, there is no detectable
signal of SLF1, SSD1 and PUB1 in the FLAG-SBP1 complex, which are all observed in the
FLAG-PAB1 complexes that contain 9% of SLF1 and 3% of SSD1. Finally, a small fraction
of eRF1 is present in both the FLAG-PAB1 and FLAG-SBP1 pull-downs (2% and 3%,
respectively), suggesting that the majority of complexes are not undergoing termination.
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Component

FLAG-SBP1 complex

FLAG-PAB1 complex

RPS4B

100

100

RPL6B

49

49

RPL7A

113

130

PAB1

9

N/A

SBP1

N/A

7

eIF4E

3

56

eIF4G1

0.7

20

eIF4G2

0.5

14

SLF1

0

9

SSD1

0

3

PUB1

0

Less than 0.5

DHH1

0

0

eRF1

2

3

Table 1.3. Stoichiometry comparison of 77S complex components associating with SBP1 and
PAB1, in percentage.
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Discussion
In the first part of this thesis, I used AUC to analyze a novel 77S complex associating with
FLAG-SBP1. The overall results support the idea that SBP1 is associating with a
translationally active 77S mRNP, which appears to be distinctive from the previous 77S
complex purified by FLAG-PAB1. This finding provides insight as to the role of SBP1 in
translation and more importantly improves the current understanding of the 77S mRNP in
translation.

SBP1 is an abundant component of the 77S mRNP
According to the previous publications in our group, SBP1 is one of the minor components of
the 77S mRNP co-purified with FLAG-PAB1, present within about 7% of the FLAG-PAB1
complex. With the use of FLAG-SBP1 as the purification handle instead, I detected a decent
amount of 77S complexes as determined from both AU-A260 and AU-FDS results. Although
SBP1 is not believed to be a critical factor in translation, as deletion of SBP1 does not cause
any noticeable phenotype, my results suggest SBP1 is abundantly associating with the 77S
mRNP. Moreover, in FLAG-SBP1 complexes, the stoichiometry of PAB1 is 9%, a close
amount to the presence of SBP1 in the FLAG-PAB1 77S complex. Assuming there is no
binding preferences of the 77S mRNP to FLAG-SBP1 or FLAG-PAB1, the overall
abundance of 77S mRNP associating with FLAG-SBP1 within the cell should be also close to
what is associating with FLAG-PAB1.
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SBP1 is participating in the 77S mRNP in the late elongation and termination phase
Previously, the abundance of the eIF4E, eIF4G1, and eIF4G2 factors in the FLAG-PAB1 77S
monosomal translating complex was determined under both steady state elongation
conditions and during elongation soon after initiation of translation (Wang 2013). Dr. Wang’s
results indicated that there were 50% to 66% more of these initiation factors present in the
77S complex early in initiation as compared to steady state elongation conditions. These
results were interpreted to indicate that these initiation factors come off the 77S translating
complex moves from initiation through elongation to termination. These results were used as
a basis to understand the low abundances of these initiation factors in FLAG-SBP1 77S
complexes.

Translation initiation factors eIF4E, eIF4G1 and eIF4G2 have very low abundance in the 77S
mRNP associated with FLAG-SBP1, with the stoichiometry of 3%, 0.7% and 0.5% as
compared to RPS4B, respectively. This result suggests that most of the FLAG-SBP1 77S
mRNP are not at the early stages of elongation following translation initiation, but likely are
fairly far advanced in the elongation phase after the initiation factors have been removed
(Wang X, 2013). There is very little overlap between SBP1 and the initiation factors and
PAB1, which also indicates that the translation initiation factors are exiting the 77S mRNP
during elongation as the poly (A) tail is being shortened and either prior to or at the same
time that SBP1 binds to the mRNP. These observations support the model that SBP1
preferentially binds the 77S complex after the initiation factors have been removed. Whether
SBP1 plays an active role in this removal remains unknown.
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Following the glucose deprivation treatment when translation ceases, the abundance of
eRF1-GFP was increased in FLAG-SBP1 complex but decreased in the FLAG-PAB1
complex (Zhang C et al 2014), possibly suggesting that more termination factors are binding
to the FLAG-SBP1 77S mRNP to terminate translation. This possibility also supports that
the FLAG-SBP1 77S complex is in a late stage of elongation.

Moreover, little of the SBP1 77S mRNP contains PAB1, which specifically and strongly
binds to the poly (A) tail. This result suggests that the mRNP has shortened its poly (A) tail to
less than 24 residues. Without the poly (A) tail this would suggest that the mRNA is not able
to form the close-loop structure or to be translated again. An alternative possibility is that an
unknown mechanism prevents PAB1 binding to the poly (A) tail in this FLAG-SBP1 77S
complex. Such factors could be deadenylation factors that SBP1 may have some functional
relation to. A third possibility is that SBP1 binding directly prevents PAB1 binding, although
there is no evidence for this.

In either case, the mRNA without PAB1 and associating with

SBP1 may be close to the end of its translational life and may soon enter P bodies or stress
granules and targeted for degradation. The role of SBP1 in this 77S mRNP is possibly
connected, therefore, with the promotion of translation termination and mRNA degradation.

PAB1 co-localizes with SBP1 in a variety of complexes including the 77S mRNP
According to the initial scans of during the AU-FDS analysis of the raw data (data not shown)
PAB1-GFP was observed to have high affinity to FLAG-SBP1. However, there was only a
small amount of complexes sedimenting to the bottom of the centrifugal cell, with the
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majority of the fluorescent signal only travelling a short distance during the experimental
period (4-5 hours of centrifugation at 15000 rpm). As a result, only a few complexes with low
signal level are observed in our interested size range (20S to 250S). There is a strong signal
below 10S (full peak not shown in the current scale), which is the undifferentiated small
complexes (including possibly monomeric PAB1-GFP) in the sample (Fig. 10 A). According
to previous findings, SBP1 and PAB1 are both mRNA binding proteins, and it is possible that
these complexes are the mRNA molecules that bind with both FLAG-SBP1 and PAB1-GFP.
Another set of very small peaks running higher than 100S are also present in the results.
These seem to be related to the polysomes. There is no peak between 30S to 70S observed,
indicating that these putative pre-initiation complexes do not contain both SBP1 and PAB1
during the translation. This conclusion is consistent with the previous suggestion of SBP1
association with the 77S complex during translation termination and mRNA degradation.

A small fraction of the FLAG-SBP1 77S mRNP containing initiation factors is not sensitive
to glucose deprivation
Following AU-FDS, PAB1-GFP, eIF4E-GFP and eIF4G-GFP had similar band patterns and
the 77S signals remained the same after glucose deprivation as in non-glucose deprived cells
(steady state conditions). These observations are contrary to our current understanding that
the 77S complex is the mRNP complex that is actively performing translation. In this case
glucose deprivation should suppress the overall rate of cellular translation which should be
reflected in the dramatic reduction of the 77S peak. This is verified by AU tests of all the
FLAG-PAB1 strains (Wang X et al 2012), as well as the GFP-tagged ribosomal components
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of FLAG-SBP1 strains. As a result, the 77S complex co-purified with the FLAG-SBP1 is
possibly containing two types of complexes. The majority is late-elongating mRNP that have
no initiation factors associated and a few (the glucose deprivation non-responsive mRNP)
contain different translation complexes. Since there might be other factors enter and exiting
between these two types of mRNP, the shape and molar mass may remain the same, resulting
in both of the mRNP running closely at 77S.

Implications for future study
With the interpretation of FLAG-SBP1 and FLAG-PAB1 results, the 77S mRNP exhibits
polymorphism in its composition and to be highly diversified in different conditions. The 77S
mRNP, despite the core constituents such as ribosomes, requires all sorts of “add-on” proteins
that temporarily associate with it in different stages. These “add-on” proteins may be critical
to controlling the assembly and disassembly of the mRNP and to turning it on and off during
translation. With single purification handles such as FLAG-SBP1 and FLAG-PAB1, we are
able to capture only a fraction of the total 77S mRNP at a certain stage. These purified
complexes would provide better subjects to the study of translational regulation and the
interactions of translational factors within a specific stage.

However it also brings a challenge to the study of the 77S mRNP comprehensively. As there
is no factor known to exclusively bind to all of the 77S mRNP, other than the ribosomes
themselves, a major problem is to obtain the stoichiometry information of target proteins in
the total 77S mRNP. With FLAG-SBP1 or FLAG-PAB1, only certain types of mRNP can be
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purified and analyzed in the AU assay. Consequently, there is a great chance that some of the
mRNP have neither of these factors and remain undiscovered. The stoichiometry data we
currently have obtained are incomplete which can only represent a certain type of mRNP. The
abundance of the total 77S mRNP and proteins in the unpurified 77S mRNP remain unknown.
Without an ideal purification handle, the total 77S mRNP can only be closely approached by
a strategy similar to the “shotgun” method of DNA sequencing, which is interpreting the data
from multiple factors binding to the 77S mRNP at different stages to reconstruct the whole
figure of this complex. The partial stoichiometry information of each type of 77S mRNP can
also be used to study the transition of factors during different translation stages and
environmental conditions.

In summary, using AU analysis on FLAG-SBP1 strains we have revealed the role of SBP1 in
translation, determined the timing of SBP1 binding to the 77S mRNP. We also captured and
analyzed a new type of 77S mRNP at a late elongation and early termination phase, adding to
our current knowledge of the translational complexes and providing a possible methodology
for future analysis.

- 46 -

Chapter II Characterization of the role of molecular chaperones in the
amyloid aggregation of Huntington’s disease

Introduction
Huntington’s disease (HD) is a fatal neurodegenerative disorder that is caused by the loss of
neuronal structure and functions. There is no cure for HD, with only a few clinical treatments
available to reduce the severity of HD symptoms. Unlike other commonly known
neurodegenerative diseases, including Alzheimer’s disease, Parkinson disease and
Amyotrophic lateral sclerosis, HD is inheritable but, related to these other diseases, is linked
with the abnormal accumulation of certain mutant proteins in neural cells, affecting the
normal functions of the central nervous system. HD can be symptomatic to patients at all ages,
but most commonly displays its phenotypes in their middle age. The onset of HD mostly
affects the basal ganglia (Fig. 2.1) which leads to conditions such as progressive dementia,
psychiatric symptoms, and choreiform movements, that culminates in premature death. Once
they begin to manifest symptoms, HD patients have an average of 17-20 years to live until
death (Myers RH, 2004).

Fig. 2.1 HD causes widespread deterioration of brain tissue, particularly of the basal ganglia.
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HD genetics
In HD patients, a mutation in the protein huntingtin (HTT), causing the expansion of the poly
glutamine (poly-Q) region of HTT, is found to be strongly related to the disease (The
Huntington’s Disease Collaborative Research Group, 1993). HTT is a 350 kDa cytoplasmic
protein expressed in human and all mammalian cells and is particularly abundant in brain and
nerve cells. Other than HTT causing HD, the actual function of HTT remains unclear. There
are several difficulties in investigating the function of HTT because HTT has no other
homologous proteins, it is widely expressed and is localized in many subcellular
compartments, and the deletion of HTT in mice is lethal to the embryos. Intracellularly, HTT
is present in nuclei, cell bodies, dendrites and nerve terminals. It has been found to associate
with vesicular and microtubule and to potentially have function in cellular trafficking and in
cytoskeleton anchoring (Hoffner G. et al, 2002; DiFiglia M, et al, 1995). Reducing the levels
of HTT leads to several phenotypes including reduced vesicle and mitochondria transport in
Drosophila melanogaster, abnormal brain development and apoptosis in the brain and testes,
and abnormal distribution and morphology of cellular organelles (Hilditch-Maguire, P. et al
2000; White, J. K. et al 1997; Auerbach, W. et al 2001) .

HTT normally contains a region of polyglutamine (poly-Q) repeat close to the N-terminus
(exon 1) that varies from 11 to 34 glutamine residues. The mutant HTT (mHTT), however,
has an expanded poly-Q region that can be as long as 103Qs. In the HTT gene, the
trinucleotide CAG repeats which encodes the poly-Q region show instability during
replication: larger repeats tend to be more unstable. The instability of CAG repeats mostly
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leads to a further expansion of the repeats (73% of the time) while contraction can also occur
(23% of the time) (Chattapadhyay B et al 2005; Djoussé L et al 2004; MacDonald ME et al
1999). The severity of the disease is found to be proportional to the length of the expansion of
the poly-Q. Thus, the expansion of CAG repeats to a certain point leads to the onset of HD as
well as the increased trend of making further expansions of itself and further development of
the disease.

Being one of the autosomal-dominant diseases, HD is not induced by terminal deletion or
physical disruption of the HTT gene. Structural studies reveal that HTT confers a toxic gain
of function in the mutation. In vitro experiments suggest that once expansion of the poly-Q
tract reaches a critical number of glutamine residues, reportedly to be 37 residues, the mutant
protein starts misfolding and aggregating. The rate of aggregation increases with the length of
the poly-Q as well as with the protein concentration. Consequently, central nervous system
cells with high expression levels of HTT are most vulnerable to the poly-Q aggregates.
Individuals with 36-40 glutamine residues have variable penetrance of the HD phenotype,
whereas HD develops full penetrance with more than 40 glutamine residues. Although no HD
cases had been diagnosed with poly-Qs below 36, the offspring of individuals with 28-35Qs
are at risk to inherit HD due to the expansion of poly-Q sequences.
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Amyloid aggregation
The aggregation of HTT results in insoluble prion-like amyloid aggregates, which accumulate
in the affected cells and can be visible by microscopy. In general, amyloids are elongated,
fibers, -sheet-rich protein aggregates which are characterized by their ability to
self-propagate and to be resistant to detergents. These attributes are found in all types of
neurodegenerative disease (Fig. 2.2A). However, it is currently not clear concerning the
mechanism of amyloid toxicity, or the role of amyloids in neurodegenerative diseases. The
mHTT amyloid has been reported to promote the aggregation of normal HTTs which do not
aggregate (Busch A et al 2003; Saleh AA et al 2014). The HTT amyloid is also able to
co-aggregate with other proteins rich in glutamine and/or asparagine, sequestrating the
normal functions of these proteins, which is believed contributory to the toxicity of mHTT in
neurodegeneration (Steffan JS et al 2000). Interestingly, the presence of wtHTT in the mHTT
amyloid slows the effect of altering the conformation of the aggregates by increasing the
solubility and reducing the toxicity caused by mHTT (Saleh AA et al 2014). Moreover,
overexpression of a Q-rich prion-like protein is also reported to neutralize the poly-Q toxicity
(Ripaud L et al 2014; Kayatekin C et al 2014). In summary, it is still controversial about the
role of amyloid aggregates in the process of neurodegeneration.
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Fig. 2.2 (A) Amyloid deposit of neurodegenerative disease in neuron cells (Soto C, 2003); (B)
The structure of amyloid aggregates (Eisenberg D and Jucker M, 2012)
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Although correlated with neurodegenerative diseases, amyloids are defined by a unique
structure pattern referred as cross- fiber diffraction pattern in which the amyloid fiber are
formed by protofibrils consisting of parallel or similarly arranged -strands perpendicular to
the length of the fiber (Fig. 2.2B). During aggregation, a segment of the protein backbone
may expose the N-H groups and the C=O groups, allowing the formation of the hydrogen
bonds with other chains. The exposure of backbone amide groups can be caused by several
different conditions including denaturing of normally folded proteins (Chiti F et al, 1999);
overwhelming chaperones by overexpression of a protein (Wang L et al, 2008); cleaving a
peptide (such as Aβ) from a folded protein; or expansion of a specific region of a protein
(poly Q diseases). In addition, amyloid aggregation also requires sufficient concentration of
the exposed proteins. For the amyloid aggregation, it is necessary to form a core aggregate
consists of three or four protein molecules. The core aggregate also reduces the free energy
required for normal proteins to expose the protein amid backbone, significantly accelerating
the rate of aggregation (Nelson R et al, 2005).

Despite the appearance in neurodegenerative disease, there are several types of amyloid
found with biological functions. For example in yeast, translation termination factor Sup35p
(eRF3 in humans) has two states: normal state [PSI-] and prion state [PSI+]. Yeast strains
carrying the [PSI+] have the ability to convert [PSI-] strains into its prion form. The [PSI+]
state deactivates the normal function of Sup35p as a translation terminator, allowing
ribosomes to read through early termination mutations. Although more than half of the
artificially induced [PSI+] strains are lethal or weak (Nakayashiki T, et al 2005; McGlinchey
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RP, et al 2011), they gain growth advantages under specific conditions including that of
ethanol or lithium presence (True HL et al 2000). As a result, except for the Sup35p
loss-of-function, the amyloid aggregate appears harmless to yeast cells.

Molecular chaperones alter the toxicity of the mHTT
Because amyloid aggregation is believed to be related to misfolding, molecular chaperones
are considered to be involved in this process. Molecular chaperones are proteins with the
primary function of assisting newly synthesized proteins to fold into the correct
three-dimensional conformation. Chaperones are hence involved in a general mechanism of
preventing protein misfolding and aggregation. Originally, molecular chaperones were
discovered as heat shock proteins (HSPs), which are induced by heat shock. Heat stress
increases the chance of protein misfolding and aggregation, whereas molecular chaperones
are proven to provide protective mechanisms against heat stress (Ellis RJ et al 1991).
Chaperones, in particular Hsp70 and co-chaperone Hsp40 families, recognize and bind to the
exposed hydrophobic amino-acid residues and unstructured backbones of a misfolding
peptide,

which

has

a

great

tendency

of

aggregate

with

each

other

in

a

concentration-dependent manner and to refold the peptide to the correct conformation with an
ATP-driven mechanism (Hartl FU et al 2011; Kim YE et al 2013). Moreover, Hsp70 and
Hsp100 chaperones are also able to synergistically disaggregate the insoluble aggregates
formed by misfolding proteins. Hsp70 disentangles the peptides from aggregates while
Hsp100 further unfolds the peptides by translocation through the central channel of Hsp100
complex in an ATP-driven mechanism (Liberek K et al 2008; Nillegoda NB, Bukau B 2015;
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Nillegoda NB et al 2015b).

Research shows molecular chaperones are also involved in the aggregation of the amyloid in
HD and other neurodegenerative diseases, although with diversified effects. The
overexpression of Hsp70 chaperone family members suppresses the cytotoxicity of mHTT
without altering the amyloid formation in mammal cell models. The aggregation of amyloid
is suppressed only if a member of Hsp40 co-chaperone is simultaneously expressed (Zhou H,
et al 2001; Rujano MA, et al 2007; Jana NR, et al 2009; Ormsby AR 2013). The
overexpression of Hsp40 family members YDJ1 and SIS1 in yeast also alters the localization
of amyloid formation between cytosol and nucleus. Amyloid deposits in the latter case is
more harmful to the cell. Interestingly, deletion of Hsp40 or Hsp70 in yeast also rescues yeast
from lethality caused by mHTT (Meriin AB et al 2002). In addition, a yeast specific
chaperone Hsp104, which is has no homologs in metazoans, is not only important to
preventing the formation of the aggregates in yeast but also suppresses the toxicity of mHTT
in other model species including C. elegants, D. melanogaster and transgenic mice (Jackrel
ME et al 2013; Lee DH et al 2010; Vacher C et al 2005). Dramatically, both overexpression
and deletion of Hsp104 in the yeast model prevents the aggregation of mHTT (Krobitsch S et
al 2000). In addition, deletion of Hsp104 in yeast increases the size and decrease the number
of [PSI+] prion aggregates and may eventually convert [PSI+] yeast into [PSI-];
overexpression of Hsp104, on the other hand, results in “diffusion” of smaller aggregates that
can be possibly degraded by proteolytic mechanisms (Wegrzyn RD et al 2001; Cox B et al
2003).
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These findings suggest Hsp104 is able to disaggregate large amyloid deposits into smaller
aggregates, and more interestingly, indicates that the toxicity of amyloids may be size related:
break down of large aggregates produces propagation “seeds” to increase the rate of
aggregation but also increases the chance of elimination of small aggregates by proteolytic
mechanisms. In summary, molecular chaperones play a critical role in prion propagation.
Moderate level of chaperones increase the size, amount, and toxicity of the amyloid
aggregates; deletion or overexpression of these chaperones, in contrast, suppress the toxicity
by altering the size, amount and distribution of the amyloid aggregates.

The poly-Q tract and the flanking sequences also determines the toxicity of mHTT
Additionally, the cytotoxicity in HD may be caused by a fragment of the mHTT, for the full
length HTT, regardless of wild-type or mutant form, appears benign to the cells. Since the full
length HTT is a huge protein, with its correct three-dimensional confirmation there is little
chance for the aggregation and self-propagation of the poly-Q tract to occur. In fact, the
“stacked” -sheet confirmation of amyloid is highly sequence sensitive and requires a large
number of glutamine residues for its structure, as only the poly-Q tract is aggregated in the
amyloid. The N-terminus of the mHTT containing an expanded poly-Q sequence is prone to
be cleaved and released by caspases or other proteases. The cleaved N-terminal fragment,
which is mostly the exon I of mHTT alone, is observed to be self-aggregating and capable of
inducing the neurodegeneration phenotype. As expected, inhibition of caspase activities
reduces both toxicity and the amyloid aggregation of mHTT in tested subjects (Graham RK,
et al 2000; Wellington CL, et al 2002). Nevertheless, expansion of the CAG repeats also
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promotes aberrant splicing of the HTT gene and results in the synthesis of an exon I fragment
which is similar to the caspase cleaved fragment (Sathasivam K, et al. 2013). Overexpressing
exon I of mHTT appears to result in the same effect of causing neurodegeneration.

The flanking sequences to the poly-Q tract profoundly alter the toxicity of mHTT. Although
being regarded as the primary cause of HD, poly-Q expansion is not the only determining
factor of the disease. In fact, there are a least nine different neurodegenerative diseases that
are cause by poly-Q expansion in different proteins. The different types of poly-Q aggregates
affect different regions of the central nervous system, resulting in different phenotypes of
neurodegeneration. Research suggests that the difference among the poly-Q containing
proteins may also contribute to the tissue preference of amyloid formation. In HD, the
flanking sequences adjacent to the poly-Q in exon I product fragment N17 and C38, the 17
amino-acid residues in the N-terminus and the 38 amino-acid residues in C-terminus
respectively, are also critical to the amyloid formation and toxicity of the poly-Q region. With
the presence of the N17 sequence, the rate of poly-Q aggregation is significantly increased
while deletion of N17 suppresses aggregation (Tam S, et al 2009). Interestingly, it is not
necessary for the N17 to be adjacent to the poly-Q tract to display this effect: N17 expressed
at the C-terminus of mHTT is similarly effective in promoting aggregation. Analysis on the
N17 structure suggests that the amphipathic residues of N17 are essential for poly-Q
aggregation. Replacing them with alanine also dramatically blocks the poly-Q aggregation
and cytotoxicity (Tam S, et al 2009). Moreover, replacing N17 with FLAG-peptide
(DYKDDDK) is also found to promote the poly-Q cytotoxicity in yeast models, with a
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similar locus independent manner (Duennwald ML, et al 2006). The C38 fragment,
nevertheless, stabilizes the poly-Q from aggregation and inhibits the cytotoxicity of poly-Q
expansion (Duennwald ML, et al 2006). The C38 fragment is mostly made up with proline
and contains 28 proline residues. The presence of this proline-rich fragment inhibits the
cytotoxicity of the expanded poly-Q fragment, and deletion of C38 stimulates the aggregation
of poly-Q as expected. Furthermore, attaching an oligoproline to the carboxyl-terminus of a
poly-Q protein can decrease the rate of amyloid aggregation (Duennwald ML, et al 2006,
Wetzel et al 2006). Noticeably, many other poly-Q proteins also contain proline-rich regions
adjacent to the poly-Q tracts, which is likely an evolutionary derived stabilizer of the poly-Q
tract for preventing aggregation in cells (Bhattacharyya A. et al 2006).

Modeling of HD
During past decades, several model systems of HD with a variety of species have been
developed. The studies of HD in model organisms are invaluable in elucidating the molecular
basis, genetics, behavior, and clinical treatment of HD. One popular model organism is that of
the budding yeast Saccharomyces cerevisiae. Expressing of mHTT in yeast resulted in
amyloid aggregation and cytotoxicity, while the wild-type HTT remained soluble and
non-toxic (Meriin AB et al 2002). This research suggested yeast was a possible model of HD
research. Yeast has already been extensively used in other protein misfolding and cellular
damage studies. A vast majority of cellular processes, such as protein synthesis, translational
control and chaperones, are highly conserved between human and yeast cells. Yeast is the
first eukaryote to have the whole genome sequenced, and the yeast genome is one of the best
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studied genomes, which provides us sufficient background information about all the factors
we may find to be involved in the amyloid formation. In addition, yeast also contains several
native prion-like proteins including SUP35, URE2, RNQ1 and SWI1, which can potentially
aggregate into amyloids as described above (Inge-Vechtomov SG et al 2007; Du Z et al
2008). Indeed, one of the native prions, RNQ1, is required for the mHTT to aggregate in the
yeast model (Meriin AB et al 2002). Using yeast models may provide additional information
about the interactions between the mHTT amyloid and internal prions. Although with the
limitations of yeast as a unicellular organism, there is no applicable way to study the effects
of HD on neuron-specific factors involved in HD, the yeast model is still sufficient for the
study of HD at the molecular level. In this thesis, yeast HD model has been chosen to conduct
the research on the aggregation patterns of mHTT amyloid using AU analysis.

Summary
Since neurodegeneration in HD is highly related to the propagation of mHTT amyloids, it is
necessary to investigate the factors involved in this process, in particular, the intermediate
misfolding complexes between free mHTT and insoluble amyloids. The intermediate
complexes are at the cross roads of aggregation and elimination. Investigations of the
properties of these complexes should be beneficial to the development of interventions in HD.
However, no previous study had been done on the characterization of these complexes in part
due to limitations in methods used to study these complexes. Taking the advantage of the
novel technique AU-FDS, it is possible to distinguish the soluble intermediate complexes
during amyloid aggregation, determining their sizes, components and regulation. It is also
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possible to study the role of chaperones in amyloid aggregation and localize their presence in
the intermediate complexes. Moreover, because chaperones are already known to have an
effect on the toxicity of mHTT, studies with AU may help us to connect the toxicity of mHTT
with the intermediate complexes and establish a quantification standard on the amelioration
of HD, which can be further used as a screening platform of pharmaceutical compounds.

In this part of the thesis, I studied the soluble portion of mHTT during propagation in a time
course manner. As compared with wild-type HTT, mHTT forms a set of complexes between
20S to 80S which appear to be involved in mHTT misfolding, amyloid aggregation, and cell
toxicity. Concomitantly, the effect of altering the gene dosage of several different chaperones
was also tested. My results indicate that altering the levels of chaperones could also affect the
soluble intermediate complexes in terms of size and abundance.
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Material and Methods
Plasmid configuration
All of the mHTT expressing plasmids used in this thesis were generously provided by Dr.
Michael Sherman of Boston University. To recapitulate the toxicity of mHTT in the yeast
model system, only the Exon I of the mHtt gene is necessary to be transformed into host cells
(Mangiarini L et al 1996). Importantly, without altering the toxicity of mHTT, a FLAG
peptide was fused to the N-terminus of the protein, which provided a reliable purification
handle for the protein. The proline-rich C38 fragment which suppresses the toxicity was
deleted, and an eGFP fluorescent tag was fused to the C-terminus to provide convenience in
detecting the protein. Finally, the fragment expressing the fused protein FLAG-PolyQ-GFP
was inserted into yeast expression vector pYES2 which carried a GAL1 promoter and URA3
selection marker. In particular, the following plasmids had been received and were used in
this

thesis:

pYES2-Flag-25Q-Gfp

(25Q),

pYES2-Flag-47Q-Gfp

pYES2-Flag-103Q-Gfp (103Q).

Fig. 2.3 Insert fragment of the plasmid pYES2/25Q (Addgene.org)
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(47Q)

and

Name

Genotype

TRY123

Mata leu2-3 112 trp1-1 sle2-1 ura3-1 his3-11 lys2

TRY124uT

Isogenic to TRY123 except hsp104:TRP1

TRY125

Isogenic to TRY123 except ssa1:HIS3 ssa2:LEU2

TRY123/25Q

Isogenic to TRY123 except FLAG-25Q-GFP:URA3

TRY123/47Q

Isogenic to TRY123 except FLAG-47Q-GFP:URA3

TRY123/103Q

Isogenic to TRY123 except FLAG-103Q-GFP:URA3

TRY124/25Q

Isogenic to TRY124uT except FLAG-25Q-GFP:URA3

TRY124/103Q

Isogenic to TRY124uT except FLAG-103Q-GFP:URA3

TRY125/25Q

Isogenic to TRY125 except FLAG-25Q-GFP:URA3

TRY125/103Q

Isogenic to TRY125 except FLAG-103Q-GFP:URA3

HSP104A503V/25Q

Isogenic to TRY124uT/25Q except Hsp104a503v:LEU2

HSP104A503V/103Q

Isogenic to TRY124uT/103Q except Hsp104a503v:LEU2

HSP104V426L/25Q

Isogenic to TRY124uT/25Q except Hsp104v426l:LEU2

HSP104V426L/103Q

Isogenic to TRY124uT/103Q except Hsp104v426l:LEU2

TRY123/sir2/25Q

Isogenic to TRY123/25Q except sir2

TRY123/sir2/103Q

Isogenic to TRY123/103Q except sir2

TRY123/Ssa1/25Q

Isogenic to TRY123/25Q except SSA1:LEU2

TRY123/Ssa1/103Q

Isogenic to TRY123/103Q except SSA1:LEU2

TRY123/Ydj1/25Q

Isogenic to TRY123/25Q except YDJ1:LEU2

TRY123/Ydj1/103Q

Isogenic to TRY123/103Q except YDJ1:LEU2

Table 2.1 Yeast strains and genetic background.
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Yeast growth conditions and sample preparation
Yeast strains used in this study are listed in Table 2.1. All of the strains tested are derived
from the strain TRY123, with the same genetic background. Yeast cells were grown at 30ºC
in glucose free synthetic complete (SC) medium until mid-log phase (OD600 = 0.8-1.2), with
1% sucrose, 1% raffinose and with the appropriate amino acids deficiency for plasmid
selection, respectively (Kaiser C et al 1994, Krobitsch S et al 2000). To induce the production
of poly-Q proteins, galactose was added to a finial concentration of 2%. The incubation was
continued for designated period of time and then cell pellets were collected by 8000 g
centrifugation for 3 minutes and stored at 80ºC. For each AU-FDS sample, 100 mL of yeast
culture were collected, regardless of the final cell concentration at the time of collection. The
protein content of yeast cells was extracted by the glass bead method with cell lysis buffer
containing 1mg/mL of PMSF, 1:500 dilution of Protease Inhibitor Cocktail (Sigma-Aldrich
P8215), 0.05 M of Tris Base, 0.15 M of KCl, 2 mM of MgCl2 and 10% glycerol. The
FLAG-tag and associated mRNPs were purified by affinity purification with 100 L of
ANTI-FLAG® M2 Affinity Gel (Sigma-Aldrich) at 4ºC for 2 hours, followed by a wash with
cell lysis buffer without the Protease Inhibitor Cocktail. The mRNPs were eluted with 500 L
of 0.2mg/mL FLAG® Peptide (Sigma-Aldrich) at 4ºC for 40 minutes.

AU analysis
Samples were loaded to the two-channel charcoal/Epon60K sedimentation velocity cells,
with approximately 350 L per channel. The centrifugation was started with a speed of 25000
RPM, at a temperature of 20ºC. For the AU-FDS analysis, at least 200 scans of samples were
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taken from each experiment, in about 5 hours, a period of time enough for the major
concentration boundary to migrate to the bottom of the cell. The raw data was analyzed by
Sedfit (Schuck P. 2000), with the model c(s) distribution and proper parameters. The
calculated data set of S-values was adjusted by multiplying the viscosity factor of 1.52 for the
presence of 10% glycerol in the buffer.
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Results
The AU-FDS analysis of mHTT
Based on previous results from Dr. Xin Wang who identified the unique patterns of soluble
aggregates with HTT-25Q and HTT-103Q following AU-FDS analysis (X. Wang, pers.
comm.), I first compared the aggregation pattern of an N-terminal HTT fragment carrying
different lengths of poly-Q: 25Q, 47Q and 103Q (Fig. 2.4). These HTT fragments carry a
FLAG tag at the N-terminus of HTT, the 17 N-terminal residues of HTT, the different lengths
of poly-Q, and GFP fused at its C-terminus (Figure 2.3). As described previously, the
HTT-25Q can be considered to be the non-toxic wild-type HTT, the HTT-47Q is an
intermediate mutant and the HTT-103Q is the severely toxic mutated form of HTT.

Upon

90

minutes

of

induction,

the

three

strains

expressed

the

designated

FLAG-HTT-PolyQ-GFP protein that can be purfied by anti-FLAG agarose as detected by
AU-FDS and gave the same type of results previously observed by Xin Wang in our
laboratory. All three HTT proteins displayed a major peak below 5S (presumably monomeric
forms of the HTT-GFP proteins). All three poly-Q constructs also significantly displayed a
major peak at about 22S, and several peaks dispersed of lesser abundance in the higher range
of S values. The estimated molecular weight for the 22S peak, if it were spherical, would be
approximately 580 kDa. This size indicates that the HTT-GFP proteins are aggregating, given
that the estimated size for each individual poly-Q would be about 32KDa, 34KDa and 42
KDa, respectively. There was no significant difference in the peak patterns and signal
strength of each individual poly-Q tested, indicating that soon after induction of these
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proteins that their aggregation patterns are very similar.

Fig. 2.4 AU-FDS analysis of HTT-25Q, -47Q and -103Q at 90 min after induction.

The polyQ aggregation differs over time
As Dr. Xin Wang had shown that the aggregation pattern for HTT-103Q changes with time in
the first 24 hours after induction, and remains the same afterwards in 48 hours and 66 hours. I
subsequently conducted a time-course assay to investigate the effect of poly-Q length on
aggregation over an expanded time period of induction. The samples of two additional
post-induction time points, 6 hours and 24 hours, were collected. With HTT-25Q, the
AU-FDS results at 6 hours and 24 hours displayed no significant differences from that of the
90 minute result, except for higher peaks indicating an increased amount of HTT-25Q protein
was produced (Fig. 2.5A). In contrast, AU-FDS analysis of the HTT-103Q construct resulted
in a dramatic shift in peaks patterns at both the 6-hour and 24-hour times of induction (Fig.
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2.5B). There are four peaks close to 80S, 110S, 150S and 170S that appeared in the 6-hour
sample that were not present in the HTT-25Q 6 hour sample. These four peaks disappeared in
the later 24-hour sample of HTT-103Q. The 22S peak in both time points was also
significantly lower than that of the HTT-25Q. A different set of peaks between 30S and 60S
also appeared in the 6-hour sample for HTT-103Q that was different at 6 hours for the
HTT-25Q sample. These 30-60S peaks remained in the HTT-103Q samples after 24 hours
with some shifts in abundance and perhaps sizes.

In summary, comparing the 24-hour HTT-103Q sample with that of the HTT-25Q, the
HTT-103Q sample had a dramatic decrease in the 22S peak, all of the peaks above 60S
disappeared while three peaks migrating approximately at 30S, 40S and 50S do not appear
similar to the peaks found in the HTT-25Q analysis. These new peaks that appeared in the
6-hour and 24-hour samples for HTT-103Q are therefore likewise related to the complexes
involved in the propagation of HTT-103Q.
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Fig. 2.5 Time-course analysis of the aggregation of HTT-25Q and -103Q
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The effect of altering HSP70 gene dosage on the aggregation of HTT-polyQ
As described above, deletion and overexpression of Hsp70 family proteins alone alters the
toxicity of mHTT but does not affect the propagation of amyloid fibrils. I subsequently
examined the effects of deleting the HSP70 genes on the HTT-103Q aggregation pattern. In
yeast there are two HSP70 genes, SSA1 and SSA2. Deletion of both of these genes resulted in
several effects on both HTT-25Q and HTT-103Q aggregation phenomenon (Fig. 2.6 A and B).
First, the overall fluorescent signal that was obtained for either HTT-25Q or HTT-103Q was
reduced. However, as observed in the wild-type strain, HTT-25Q had the same set of peaks at
all time points with the hsp70 deletion, but the signal strength of 6-hour sample was similar
to the 90-minute curve. This lack of increase in abundance with time for the HTT-25Q peaks
differs from that of the wild-type strain (Fig. 2.5 A).

Moreover, a more significant change was observed for HTT-103Q with the hsp70 deletion. At
the 6-hour time point, the peaks discovered in the wild-type strain (Fig. 2.5 B) were
completely absent and the peak pattern was similar to that observed for the HTT-25Q samples.
Although the lower range of peaks eventually came back at 24-hour for the HTT-103Q
sample, they lacked the 50S peak compared with the wild-type strain at 24 hours. This
observation suggests HSP70 is one of the factors controlling the aggregation pattern of
HTT-103Q and is important to the control of degree of aggregation for both HTT-25Q and
HTT-103Q.
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Effect of overexpression of SSA1 on HTT aggregation
In addition, strains overexpressing HSP70 (SSA1) were also analyzed. In this case, the
HTT-25Q samples displayed reduced abundance in the 6-hour sample, and overall the peaks
appeared to be similar to that observed in the wild-type (Fig. 2.6 C), suggesting alterations in
the synthesis or degradation of HTT-25Q. Interestingly, overexpression of HSP70 also
significantly affected the peak patterns observed with the HTT-103Q sample at the 6-hour
time point, in which only the 22S peak and a 30S peak were present. All the rest of the peaks
observed in the wild-type strain were absent (Fig. 2.6 D). At the 24-hour time point the effect
of overexpression of HSP70 was similar to that found for HTT-103Q in the wild-type strain
in that the 22S, 30S, 40S and 50S peaks, with an additional peak observed at approximately
75S, were observed. As overexpression of HSP70 is also reported to be suppressing the
toxicity of mHTT (Zhou H, et al 2001; Rujano MA, et al 2007; Ormsby AR 2013), these
results on the deletion and overexpression of Hsp70 family member SSA1 share the similarity
at the 6-hour time point that a series of peaks in the higher S value range (80S and above)
were suppressed in both cases, supporting these as aggregation-related complexes linked to
toxicity. For the 20 to 80S region, HSP70 deletion reduced these complexes, whereas
overexpression had less effect, especially at 24 hours post induction.
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Fig. 2.6 (A, B) AU-FDS analysis of HTT-25Q and HTT-103Q in the hsp70 deletion strain.
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Fig. 2.6 (C, D) AU-FDS analysis of HTT-25Q and HTT-103Q in a strain overexpressing
SSA1 (HSP70)
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Effects of deleting HSP104 on polyQ aggregation
As described above, HSP104 is a yeast specific chaperone found to promote disaggregation
of amyloids. Deletion of the HSP104 gene also repressed the aggregation of mHTT in yeast
(Meriin AB 2002). In the following experiment, the deletion of HSP104 and the effect of two
variants of the HSP104 gene strains were analyzed by AU-FDS for effects on HTT-103Q
aggregation. In the hsp104 deletion strain, no major effects on HTT-25Q were observed
except for the reduction of signal strength at the 24-hour time point (Fig. 2.7 A and B). In
contrast, the hsp104 deletion displayed strong effects on the HTT-103Q peaks at the 6-hour
and 24-hour time points: all of the peaks in the high range (above 80S) presumably involved
in the aggregation of HTT-103Q amyloids were significantly repressed. For the HTT-103Q
peaks of smaller size, only a small 60S peak was observed at the 24-hour time point. These
results indicate a strong correlation between the soluble aggregates observed with HTT-103Q
and their effects on amyloid formation and cytotoxicity.

In addition, two variants of HSP104, carrying mutations of A503V and V426L were tested in
the study. HSP104A503V and HSP104V426L are two optimized variants of HSP104 which
display enhanced function in chaperone activities. These HSP104 variants were reported to
antagonize the toxicity of several different types of neurodegenerative diseases (Jackrel ME
et al 2014). Following AU-FDS analysis, these two variants exhibited similar effects on the
aggregation of HTT-103Q, while no alterations on HTT-25Q aggregation were observed (Fig.
2.7 C, D, E and F). In both variants for HTT-103Q, a pair of major peaks running at 60S and
80S appeared in the 6-hour time point and significant material larger than 80S was observed.
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This pattern is most similar to that of the strain carrying the wild-type HSP104. These larger
peaks also disappeared at the 24-hour time point similar to wild-type. Additional peaks
running at 30S to 80S were also observed at the 24-hour time point. It should also be noted
that in the 30-60S region for the 24-hour time point for these two variants that the results
display similarities to the wild-type results at 24 hour. Overall these two HSP104 variants are
displaying more modest effects on HTT-103Q aggregation patterns.

Fig. 2.7 (A, B) AU-FDS analysis of HTT-25Q and HTT-103Q in an hsp104 deletion strain.
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Fig. 2.7 (C, D) AU-FDS analysis of HTT-25Q and HTT-103Q in HSP104A503V mutation
strain.
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Fig. 2.7 (E, F) AU-FDS analysis of HTT-25Q and HTT-103Q in HSP104V426L mutation
strain.
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Overexpression of Hsp40 family member YDJ1
The co-chaperone YDJ1 of the Hsp40 family is a regulatory factor that interacts with the
Hsp70 chaperones to regulate their activity. Overexpression of Hsp40 along with Hsp70
reduces the size and amount of amyloids formed in different neurodegenerative diseases
(Rujano MA, et al 2007; Ormsby AR 2013). The effect of YDJ1 overexpression on HTT
aggregation was subsequently analyzed (Fig. 2.8). No effect of YDJ1 overexpression was
observed on HTT-25Q aggregation. In terms of HTT-103Q aggregation, overexpression of
YDJ1 resulted in a set of peaks similar to the results of two HSP104 variants and wild-type:
similar major peaks were present at 30S, 40S, 60S and 80S at the 6-hour time point. The
24-hour result for the YDJ1 overexpression was also similar to that observed for the HSP104
variants and the wild-type strain. These results imply that overexpression of YDJ1 is having
little effect on HTT soluble aggregation.
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Fig. 2.8 AU-FDS analysis of the effects of overexpression of YDJ1 on the aggregation of
HTT-103Q.
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Overexpression of heat shock transcription factor HSF1
The heat shock factor (HSF1) is a transcription factor inducing the expression of heat shock
proteins. It is also found to be a regulator of aging that increases the lifespan in yeast (Hsu AL
et al 2003; Ohtsuka H et al 2011; Riva L et al 2012). Overexpression of HSF1 increases the
overall expression of HSPs and suppressed the age depending aggregation of HTT-47Q
(Cohen A et al 2012). To begin to look at possible effects of aging on HHT-103Q aggregation,
the effects of overexpression of HSF1 were analyzed.

As shown in Figure 2.9, HSF1 suppressed the aggregation complexes observed with
HTT-103Q following AU-FDS analysis. For HSF1 overexpression only the 22S, 30S, 40S
and 60S peaks but no peaks in between 80S and 180S were present in the 6-hour sample.
Additionally, the overall peak pattern of the 6-hour samples was similar to that observed for
the HTT-25Q sample, except for the slightly increased 60S peak. This indicates that the
aggregation was less pronounced at this earlier stage than for other strains tested. Similar
effects were also observed in the hsp70 deletion and hsp104 deletion strains. Unfortunately,
because the 24-hour sample of HTT-103Q was lost during the experiment, the overall effect
of HSF1 overexpression cannot be completely evaluated here.
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Fig. 2.9 PolyQ aggregation in a HSF1 overexpression strain.

Deletion of sir2 results affects the HTT-103Q aggregation pattern
SIR2 is another anti-aging factor that promotes the activities of chaperones under stress. The
deletion of sir2 was found to promote the aggregation of poly-Q in yeast cells (Sorolla MA et
al 2011; Cohen A et al 2012). I subsequently tested the effect of deleting the SIR2 on
HTT-103Q aggregation. Deletion of SIR2, as expected, dramatically changed the complexes
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found with HTT-103Q while the HTT-25Q aggregates remained unaffected (Fig. 2.10). For
HTT-103Q at the 6-hour time point, only three major peaks running between 20S and 60S
were observed in the AU-FDS results. None of the larger 80-180S peaks were observed that
was present in the wild-type SIR2 yeast strain (Figure 2.5B). At 24 hours, the three peaks
were observed in the same pattern with increased abundance, although a slight shift in sizes
of the peaks was also observed, which is most likely due the human and instrumental errors
in determining the meniscus of the sample. Because the 24-hour sample had a clearer
background signal without the disturbance of the undifferentiated complexes below 5S, the
sizes of the three complexes should be 22S, 30S and 40S. These three peaks may be related to
the three peaks observed in the HTT-103Q sample at 24 hours in the wild-type strain.
Because the sir2 deletion stain is supposed to have a faster rate of poly-Q aggregation, my
results are consistent with the sir2 deletion resulting in the 24 hour pattern characteristic of
HTT-103Q being obtained at a much earlier time point (6 hours in this case). These data
further suggest that this unique peak pattern may be related to a specific HTT-103Q
aggregation pattern.
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Fig. 2.10 PolyQ aggregation in a sir2 deletion strain.
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Discussion
In this chapter using AU-FDS analysis, we have observed a set of protein complexes involved
in HTT protein aggregation. The role of chaperones in HTT aggregation was subsequently
addressed, allowing us to further characterize which HTT aggregates were playing critical
roles in the aggregation process.

The effect of expressing mHTT in yeast
According to previous research, expressing mHTT results in a single large cytoplasmic
aggregate in yeast cells, in contrast normal HTT (HTT-25Q) did not aggregate (Krobitsch S
and Lindquist S 2000). With the expression of the prion protein RNQ1, expressing mHTT
was toxic to yeast cells, as they stopped growing after the mHTT expression was induced
(Meriin AB et al 2002). In my experiments, the strain TRY123/103Q primarily used as the
positive control of mHTT toxicity also developed similar phenotypes of toxicity after
induction of HTT-103Q expression. When plated with low concentration on selective
galactose plates, no observable colonies were formed by TRY123/103Q after a significant
period time of incubation (>72 hours). Suprizingly in liquid medium, when the induction was
performed in mid-log phase, the growth of the TRY123/103Q strain appeared to be impaired
but not stopped, as the OD600 of the culture was still increasing. Meanwhile a large amount
of yeast cells were observed to be dramatically increased in their sizes, after 24 hours of
induction. The differenciated morphology of yeast cell under microscopy is likely to be
caused by the instability of the 103Q plasmid. As reported, only a small portion of yeast cells
were able to retain the 103Q plasmid after a long period of 103Q synthesis, even if incubated
- 82 -

with a selective medium (Meriin AB et al 2002). With the stress from both selective medium
and mHTT aggregation, in either case, the growth of the yeast in the inductive medium
should be significantly reduced. As a result, the increase of OD600 in the cell culture may be
occurring not only because of increasing cell numbers but also by the increase in the sizes of
the yeast cells.

The general distribution of HTT-25Q
For every strain expressing HTT-25Q, despite overall differences in the c(s) levels (which
varied between strains and time points) a unique peak pattern was observed. This pattern
included a huge undifferentiated peak below 5S, a 22S peak with moderate abundance and a
series of dispersed low abundance peaks gradually descending from 30S to 180S. The
undifferentiated 5S peak was calculated from the background fluorescent signal which did
not sediment during centrifugation. This peak is likely to representing the monomeric
HTT-25Q proteins in the solution. The 22S peak and the subsequent dispersed peaks, in
contrast, represent a set of complexes much larger in size, indicating some of the HTT-25Q
was aggregated into large oligomers. It is necessary to note that this type of aggregation was
of a different type of aggregation of poly-Q that has previously been shown to not result in
amyloid formation and therefore, would not be toxic to the cells.

It should be noted that since the complexes 22S in size and larger contain presumably
multiple molecules of HTT-25Q, the peak abundances of these complexes as detected by
AU-FDS may actually be exaggerated by multiple copies of the HTT-25Q-GFP proteins.
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What this means is that, if we assume that the increase in S value is due to increased numbers
of HTT-25Q associating in a particular complex, as the S value increases and the mass
increases, the fluorescent signal increases. This results in the fluorescent signal providing
higher than expected values and the actual abundances of the complexes as they increase in S
value would be lower than visualized in the Figures presented.

Two types of aggregation in HTT-103Q expressing strains
As compared to the results observed with HTT-25Q, the aggregation of HTT-103Q was much
different. While at 90 min post-induction, all of the HTT-103Q complexes had the same set of
peaks as observed with the HTT-25Q results, later time points identified a number of large
complexes. According to the abundance changes of HTT-103Q monomers over time in the
wild-type strain, the aggregation of the misfolding HTT-103Q mainly occurred during the 90
min to 6 hr period. This is reflected in the unique peak patterns of the 6 hr results, in which
the 22S peak became reduced, a set of discrete peaks were observed in the range of 80S to
180S, and a new pattern was observed in the 30-50S region. In contrast, by 24 hr, the large
peaks above 80S became absent and the abundances of the 30-50S peaks were different than
observed at 6 hr. Therefore, these large transient complexes (greater than 60S) are likely to be
the intermediates of amyloid formation; whereas the 30S-50S peaks present in both time
points are more likely to be the terminal soluble aggregation form for HTT-103Q and appear
to coexist with the presence of the amyloids. Therefore, in the wild-type strain, the presence
of this set of large complexes suggests a different type of soluble protein aggregation that
leads to the formation of insoluble amyloids occurring after 90 min of induction, before
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which, the aggregation pattern was similar to that of HTT-25Q.

Since I found these peaks between 20S and 80S varied in abundance by altering the dosages
of different chaperones, these results indicate that these peaks are related to the misfolding of
HTT-103Q. As a result, HTT-103Q is likely to be synthesized in an unstable native state
which behaves and looks similar to that of HTT-25Q and which forms similar types of
oligomeric structures in the 22S to 60S region. Following 90 min, the misfolding of
HTT-103Q takes place, as observed at the 6 hr time point. This misfolding resulted in the
aggregation of multiple larger complexes both in the 30-50S region and definitely in the 80S
and larger region and eventually the formation of insoluble amyloid material.

The amyloid aggregation of HTT-103 results in significant loss of the monomeric form of the
protein
Based on the results obtained, the signal migrating below 5S, which is presumably the
monomeric form of poly-Q, increased over time and remained in high abundance in all
HTT-25Q samples. In contrast, in the wild-type strain, the monomeric HTT-103Q had
reduced abundance in 6 hr and 24 hr as compared to the 90 min samples. This effect was
enhance in the overexpression or increased activity of chaperones, and was suppressed in the
strains carrying deletion of HSP70 and HSP104 and in the HSF1 overexpression strain (Fig
2.11, only HTT-103Q results are re-scaled). The reduction of the monomeric HTT-103Q was
also coupled with the presence of the large complexes related to the misfolding aggregation
of HTT-103Q. With only soluble complexes being analyzed, the majority of the HTT-103Q
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protein may be present in the amyloid, which is too large for FLAG agarose purifications.
Therefore, the complexes observed in the results that I present are likely to be the
intermediate aggregates of HTT-103Q in the process of amyloid formation.
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Fig 2.11 Rescale of the 2.5S peak of HTT-103Q in different strains.
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Absence of the HSP70 and HSP104 chaperones reduce the overall rate of amyloid
aggregation.
Although regarded as a self-propagating process, during the time points tested in this thesis,
the amyloid aggregation of poly-Q relied on the presence of chaperones and other cellular
factors. Deletion of chaperone HSP70 strongly prohibited this overall process, with very low
abundance of all aggregation complexes (both the 30-50S material at both the 6 hr and 24 hr
time points and the material larger than 80S at 6 hr). There was also more monomeric
HTT-103Q observed at these time points as compared with the wild-type (Fig. 2.11). These
results are consistent with the model that the HSP70 gene is required for HTT-103Q
monomer to oligomer aggregation. Because it has previously been shown that deletion of
HSP70 resulted in smaller amyloids of HTT-103Q that suppressed the toxicity of mHTT in
yeast (Meriin AB et al 2002), my results indicate that the repression of toxicity by hsp70 is
likely due to the overall slower rate of poly-Q aggregation in this chaperone deletion strain.

The deletion of HSP104 also had major effects on HTT-103Q aggregation. In this case, and
unlike that of deleting HSP70, the overall pattern looks more similar to that of HTT-25Q than
it does to the HTT-103Q pattern in the wild-type strain. Also, the hsp104-containing strain
did not display the reduction of the monomeric HTT-103Q material with time that was
observed in wild-type. Therefore, deletion of HSP104 appears to strongly block the
aggregation process and suppresses the formation of all soluble aggregates greater than 22S.
Because deletion of HSP104 blocks HTT-103Q toxicity and results in the formation of a
single non-spreading amyloid, my results are consistent with these hsp104 effects being the
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result of the blockage of the soluble oligomerization process that we have observed.

The formation of soluble aggregates was affected by SSA1 overexpression
Despite suppressing the toxicity of HTT-103Q, overexpression of HSP70, or enhancement of
HSP104 did not significantly suppress the formation of the HTT-103Q amyloid (Zhou H, et
al 2001; Rujano MA, et al 2007; Jana NR , et al 2009; Ormsby AR 2013; Jackrel ME et al
2013; Lee DH et al 2010; Vacher C et al 2005). For my results, overexpression of SSA1 at the
6 hr time point resulted in blockage of all large aggregates (greater than 60S) and significant
reduction in the 30-50S aggregates (Figure 2.6D). AT 24 hr, however, the pattern displayed
with SSA1 overexpression was similar to that of the peak patterns as compared to the
wild-type strain with only one additional 75/80S peak being present. These results suggest
that the aggregation process is being affected, which might be the cause of SSA1 effects on
HTT-103Q toxicity. However, given that the 24 hr soluble aggregation pattern is similar for
SSA1 overexpression as it is for wild-type, there may be no effect of SSA1 overexpression on
insoluble amyloid formation, which is in agreement with published results. Therefore, the
soluble complexes may be more related to HTT-103Q toxic effects than the large insoluble
amyloid.

In contrast to these results, overexpression of YDJ1 displayed less noticeable effects on the
6h and 24 hr HTT-103Q aggregation patterns (Figure 2.8B). Both the larger than 60S
complexes were observed at 6 hr and the 30-50S complexes appeared similar to that of
wild-type at both 6 and 24 hr. Since overexpression of YDJ1 does not affect HTT-103Q
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toxicity or amyloid formation, these results again are consistent with the soluble aggregates
that HTT-103Q forms as being important to both toxic effects and amyloid formation.

HSF1 overexpression can have effects on HTT-103Q aggregation either from its control of
the expression of multiple chaperones or from effects on aging.
In contrast, overexpression of HSF1 had shown promising effect on the prevention of
amyloid aggregation in 6 hr (Cohen et al 2012). HSF1 is regarded as the “master” regulator
of all chaperones, overexpression of HSF1 increases the expression of all heat shock proteins
(Morimoto RI et al 1992). Multiple chaperones are known to control the misfolding process,
and therefore a global regulator like HSF1 may be having more general effects than singly
overexpressing any one chaperone. HSP70 corrects the misfolding proteins with the
assistance of co-chaperone HSP40, while HSP104 has the function of disassociating amyloids
(Zhou H, et al 2001; Rujano MA, et al 2007; Ormsby AR 2013; Jackrel ME et al 2013; Lee
DH et al 2010; Vacher C et al 2005). These chaperones are likely to have synergistic effects
on amyloid formation in that HSP70 corrects the misfolding protein disassociation from the
large aggregates of amyloid by HSP104. Overexpressing the chaperones individually may be
effective on suppressing the toxicity but the effect will be restricted by the limited presence of
other chaperones it cooperates with.

My results with the overexpression of HSF1 resulted in very high abundance of the 60S peak
at the 6-hour time point, whereas the 22S, 30S, and 40S, peaks appeared more similar to that
observed for HTT-25Q. This means that overexpression of HSF1 is delaying the onset of
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HTT-103Q aggregation, a result consistent with its known effect on amyloid formation (Riva
L et al 2012; Cohen A et al 2012).

Deletion of SIR2 significant effects on the aggregation patterns of poly-Q
Two anti-aging factors HSF1 and SIR2 were previously shown to alter the aggregation rates
of HTT-poly-Q (Cohen A et al 2012). In my results the deletion of SIR2 resulted in rapid
aggregation of HTT-poly-Q at an early stage, which was observed to generate a unique peak
pattern of aggregation with abnormally high abundance of the 40S and 30S complexes, and
very low abundance of 60S and 80S complexes. On the other hand, the overexpression of
HSF1 resulted in decreased aggregation at 6 hr as described above. Since the 40S and 30S
peaks were observed in the wild-type strain expressing HTT-103Q but in moderate
abundance, the excessive amount of these two complexes in the sir2 deletion strains correlate
with the increased toxicity linked to sir2, which is therefore linked to the amyloid
aggregation of HTT-103Q.

The enhanced function variants of HSP104 had little effect on aggregation
Two variants of HSP104 (HSP104A503V and HSP104V426L) were analyzed because
previous results had indicated that they enhanced disaggregation of misfolded complexes,
reducing the toxicity of α-syn of Alzheimer’s disease, and FUS and TDP-43 of ALS disease
(Jackrel ME et al 2014). However, my results indicate that neither variant seemed to display
large effects on HTT-103Q soluble aggregates. It is possible that these variants are unable to
function with HTT whereas they work well dissociating other types of misfolded proteins.
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The formation of 50/60S complex may be an early event of the aggregation of the amyloid
The 6-hour time point for the effect of HSF1 overexpression on the HTT-103Q aggregation
pattern and the 24-hour time point of the hsp104 deletion shared a similar pattern of peaks
that appeared identical to the HTT-25Q analyzed sample except for an increased 60S peak.
Additionally, these two particular results both suggested that the loss of HTT-103Q
monomers was delayed, as reflected in the background signal below 5S. These observations
suggest that the change in the 60S peak is an early stage of the misfolding poly-Q aggregation
pattern. Although the 60S peak was only observed in part of the strains at a particular time
point, several other strains contained a 50S peak instead. Because the sizes of these peaks
were not precisely determined, it is possible that the 50S and 60S peak were representing the
same complex (see below discussion of a similar situation with the 75S and 80S peaks). This
conclusion is supported by the observation that the hsp70 deletion strain, which had a very
strong effect on the aggregation process, also did not display the 60S peak. The sir2 deletion
strain, which is supposed to have rapid aggregation, also displayed a significant 50S/60S
peak at 6 hr. These observations suggest that the 50S/60S peak may be an early intermediate
in the aggregation process, but more analysis of time points between 90 min and 6 hr would
be necessary to further test this hypothesis.

It should be mentioned that the 75S and 80S peaks observed are also likely to represent the
same peak. For AU-FDS analysis conducted at 25000 rpm, 80S is a little larger than the range
of S values which is best resolved at this rotor speed. It is likely that systematic errors
perhaps exaggerated by human errors in these experiment result in small inconsistency of the
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size of the peaks in this range.

The linkage between HTT-103Q toxicity, amyloid formation and the AU-FDS observations
Although regarded as the most critical feature of neurodegenerative diseases, the formation of
insoluble amyloid is not directly linked to cytotoxicity. In fact, natural amyloids widely exist
in a variety of organisms with different biological functions (Hammer ND et al 2008). In the
case of HD, several factors had been discovered to suppress the toxicity or symptoms of
mHTT without altering the aggregation of amyloids, yet suppressing amyloid formation will
definitely ameliorate the disease (Zhou H, et al 2001; Rujano MA, et al 2007; Ormsby AR
2013). My results also supported that suppressing amyloid formation is not necessarily
required for the prevention of HTT-103Q toxicity, as soluble aggregates may be affecting
toxicity. For example, deletion of HSP70 or HSP104 suppressed amyloid formation and
toxicity, and I showed that they had major effects on the unique soluble aggregation observed
with HTT-103Q. Therefore, the toxicity of HTT-103Q may be determined by the type of
amyloid it forms, and whether the presence of excessive abundance of chaperones alters the
concentration of soluble aggregates. Interestingly, in the HSP70 overexpression strain, which
has reduced toxicity with little alteration in amyloid, I observed several differences in peaks
from the wild-type strain in both 6 hr and 24 hr samples with AU-FDS. Although the
compositions and functions of these peaks are not yet determined, their presence might be
relevant to the reduction of amyloid toxicity in the samples.
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Aging significantly promotes the amyloid aggregation and toxicity
Surprisingly, both of the two aging factors tested in this study greatly altered the aggregation
of HTT-103Q. A majority of neurodegenerative diseases patients get the disease symptoms at
mid-age or later, suggesting aging may be contributing to the development of the disease.
Additionally, without the replacement of new cells, most of the neuron cells have an
extra-long life span. Aging can be one of the determining factors in the neural loss of these
neurodegenerative diseases. Among the tested strains, overexpression of HSF1 had one of
three best suppression effects on the soluble aggregation pattern observed among the strains
tested, the other two being the deletion of HSP70 and the deletion of HSP104. Relatedly, the
deletion of SIR2 increased the aggregation and toxicity of the HTT-103Q amyloid (Cohen et
al 2012) and exhibits a unique peak pattern of soluble aggregates under AU-FDS. These two
results are consistent with the soluble aggregates being directly linked to toxicity. As a result,
more anti-aging factors should be tested in the future. Practically, to produce remedies against
HD, overexpression of anti-aging factors is a more likely approach, since deletion of
chaperones might clearly bring additional problems with the misfolding clearance of all
cellular proteins. Also, altering the abundance of anti-aging factors may also bring other
benefits to cells.

Future prospects
Based on the current findings on the aggregation of HTT-103Q with different factors, further
investigations are necessary to be conducted. Some of the possibilities are suggested below.
1) Increase the amount of timings on sample collection. The timing of samples I currently
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used was discrete but not capable of capturing the full description of this process. Adding
more time points between 90 min and 6 hr may help us determine the early events of and
peak patterns of soluble aggregate formation. Because HD in a yeast model is a highly
accelerated process, compared to that in humans, due to the high expression levels of mHTT
and short lifespan of yeast, detecting a small delay in the start of aggregation may correspond
to years for HD patients.
2) Determine the compositions of the (20S to 80S) peaks observed in these experiments. It is
important to know the composition and stoichiometry present in each of the peaks that
HTT-103Q is forming. As these peaks are likely to be linked with the amyloid formation or
the toxicity of HTT-103Q, such investigations may help to discover the actual roles of the
complexes in this process, and develop intervention methods that could affect their
abundances.
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General Discussion
In chapter I, I used AU-FDS analysis to characterize the 77S monosomal translating mRNP
associated with SBP1. I determined the composition and stoichiometry of other factors
associated with this 77S complex and showed that the complex was distinct from that of the
77S complex that had been previously identified with FLAG-PAB1, Based on the fact that the
77S complex that was co-purified with FLAG-SBP1 lacked translation initiation factors led
to the suggestion that this complex and SBP1 is representative of a translating monosome at a
late elongation phase or early termination phase.

In chapter II, AU-FDS analysis was used to identify the soluble aggregates present in a yeast
model of HD. Using HTT-103Q that forms amyloids and which causes cell toxicity, our
results identified a series of intermediate complexes that were formed.

These complexes,

ranged from 30-180S in size, are presumably the precursors of insoluble amyloid aggregates
previously observed by other researchers, as they occur soon after HTT-103Q induction of
expression. In that soluble aggregates in the 30-50S size range remained after 24 hr of
HTT-103Q induction, these 30-50S complexes may also be the degradation products of
amyloids or possibly stably formed precursor complexes. The effects of altering chaperone
and aging factors gene dosage on HTT-103Q aggregation was also analyzed. My results
suggest that the presence of amyloid aggregation was not always linked with HTT-103Q
toxicity in yeast, and the differences in the aggregation patterns may alter the toxicity of
amyloid.
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In both parts of the thesis, AU-FDS was used as the primary technique to conduct the studies.
As described above, the advantages of AU-FDS make it a unique tool to the studies of
macromolecular complexes in solution. In this respect, this technique worked well both in
further characterizing the 77S monosomal translating complex and for the first time in
identifying soluble complexes that are relevant to the HTT amyloid aggregation. However,
there are also a couple of disadvantages of AU analysis. First of all, although AU is capable
of analyzing samples in a broad range of sizes, the actual range of each individual experiment
was restricted by centrifugal speed. Under a certain speed, complexes larger than the
designated range will sediment to the bottom too soon, while complexes too small will result
in little sedimentation occurring. In both cases, the sizes of these complexes cannot be
precisely determined.

Additionally, AU analysis determines the S value assuming the shape of the molecule is
spherical. For complexes with unknown structure, it is impossible to determine the actual size
by AU, as the conversion of the S values to molecular weight requires defining the shape of
the factor. This might result in two complexes with the same size sedimenting at dramatically
different rates, because of their differences in the shape, or complexes migrating at the same
S value being of different composition and mass, as observed with the 77S complex.
Fortunately, carefully designed experiments may be able to minimize the error generated by
these disadvantages.

Two other limitations with AU analysis were observed in these studies. While AU-FDS
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analysis can detect unique complexes not previously visualized (Wang et al 2012), the
composition and stoichiometry of the components in these complexes are more difficult to
determine. Using a variety of GFP tagged proteins, composition and stoichiometry of
components of the 77S complex were determined for both the FLAG-PAB1 and FLAG-SBP1
complexes. But this technique was limited by the fact that the protein composition was
probed based on what we, the researchers, thought was in the complex. The presence of novel
factors in the 77S complex could not be feasibly tested. In this case, mass spectrometric
procedures would be best to determine what factors are in a particular complex. On the other
hand, we were not able to determine the composition of HTT-103Q complexes. For this type
of analysis new types of FLAG-tagged HTT constructs lacking the GFP component would
have to be generated. However, even these studies may be problematic if the lack of the GFP
were to affect HTT-103Q aggregation in yeast.

Finally, AU-FDS analysis cannot stand on its own to characterize completely the soluble
complexes identified herein and in our other studies (Wang et al 2012). Obviously, mass
spectrometric procedures would be helpful for characterizing the composition of these
complexes. Unfortunately, AU analysis does not purify the complexes. This means other
purification means (sucrose gradient analysis, possibly) would be needed to purify the soluble
complexes identified with AU analysis. Whether sucrose gradient analysis can rigorously
identify the complexes observed with AU analysis is not certain. In this regard, AU analysis
can identify and differentiate complexes not previously visualized, but their further
purification and characterization by standard procedures may not feasible.
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